Stockwinners Market Radar for January 30, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

HOOD

Hot Stocks

20:28 EST Cathie Wood's ARK Investment bought 106K shares of Robinhood today
PINS

Hot Stocks

20:27 EST Cathie Wood's ARK Investment bought 55K shares of Pinterest today
TSLA

Hot Stocks

20:26 EST Cathie Wood's ARK Investment bought 28.7K shares of Tesla today
GOVX

Hot Stocks

19:50 EST Geovax Labs Inc trading halted, news pending
DFS

Hot Stocks

19:32 EST Discover CFO sells $3.75M in common stock - In a regulatory filing, Discover disclosed that its CFO John Greene sold 35.2K shares of common stock on January 26th in a total transaction size of $3.75M.
ACRFY TNL

Hot Stocks

19:04 EST Travel + Leisure acquires vacation ownership business of Accor for $48.4M - Travel + Leisure Co. (TNL) "announced an agreement to acquire the vacation ownership business of global hospitality giant Accor (ACRFY) for $48.4M. The acquisition is expected to close in the first quarter of 2024 and to be immediately accretive to Travel + Leisure Co. earnings upon completion. Under the terms of the deal, Travel + Leisure Co. will acquire Accor's vacation ownership business, Accor Vacation Club, representing 24 resorts and nearly 30,000 members. Accor is the largest international hotel chain in the Asia Pacific with more than 1,600 hotels in operation, giving the brand a distinct advantage in its recognition across the world's most populous region. Accor will receive a percentage of vacation ownership sales revenue as a licensing fee under the exclusive licensing agreement. Travel + Leisure Co. also receives the exclusive rights to develop new vacation ownership clubs and products utilizing the Accor Vacation Club brand across a region including Asia Pacific, Middle East, Africa and Turkey."
SLB

Hot Stocks

19:02 EST SLB affirms FY24 guidance - CEO Olivier Le Peuch stated: "We acknowledge the decision by Saudi Aramco to maintain its Maximum Sustainable Capacity at 12 million barrels per day, and not to continue increasing MSC to 13 MMBD. We continue to work very closely with Saudi Aramco, and our understanding is that all ongoing oil and gas projects remain intact and that only two offshore oil increment projects not yet started will be suspended. Our forecast for significant growth for 2024 in the Kingdom remains intact. Looking ahead, the combination of our revenue mix in the Kingdom, which is weighted toward onshore and the expanding gas market, and our unique market position in other countries in the Middle East will continue to support the multi-year growth cycle in the region. As we shared during our most recent earnings release, global energy demand continues to increase, and international production is expected to play a key role in meeting supply through the end of this decade. Given this, we are confident in the strength and longevity of this cycle through 2024 and beyond."
ERJ

Hot Stocks

18:46 EST Embraer delivered 75 aircraft in 4Q23 - Embraer delivered 75 aircraft in 4Q23, with 49 executive jets (30 light and 19 medium), 25 commercial jets and 1 military C-390 jet. In 2023, Embraer supplied 181 aircraft, an increase of 13% compared to 2022 when the company delivered 160. The company continues to face supply chain delays which have affected 2023 deliveries. The company's backlog rose by $1.2B YoY, reaching a total of $18.7B in 2023 - the highest number recorded since 1Q18.
ALPMY

Hot Stocks

18:32 EST Astellas Pharma announces strategic collaboration with Mass General Brigham - Astellas Pharma announced that it has entered into a strategic collaboration with Mass General Brigham that is focused on translational medicine and early development to establish an integrated approach to scientific advancement and clinical expertise. Initial projects of mutual interest will be focused in key areas of R&D investment for Astellas, including oncology, rare disease, and cell and gene therapy. Through the alliance, Astellas and Mass General Brigham aim to: Accelerate innovation through collaborative research, as well as exploring and expanding new research frontiers; translate innovative research into clinical trials and actionable solutions that address serious unmet needs and aim to improve healthcare for all; leverage scientific and clinical expertise to inform and accelerate the development of novel therapies.
MSFT

Hot Stocks

18:12 EST Microsoft sees FY24 operating margins up 1%-2% - Expects FX to have less than 1 point of impact to FY24 results. Expects Activision to be accretive to FY24 operating income.
MSFT

Hot Stocks

18:10 EST Microsoft sees Q3 Intelligent Cloud revenue $26B-$26.3B - Sees Q3 More Personal Computing revenue $14.7B-$15.1B. Sees Q3 Productivity and Business Processes revenue $19.3B-$19.6B. Sees Q3 Office Consumer revenue growth in mid to high single digits. Sees Q3 LinkedIn revenue growth mid to high single digits. Sees Q3 Azure revenue growth stable vs. Q2. Sees Q3 Dynamics revenue growth in mid teens. Sees Q3 CapEx up "materially," sequentially. Sees Q3 currency boosting sales by less than 1%. Sees Q3: COGS $18.6B-$18.8B; OpEx $15.8B-$$15.9B; tax rate ~18%.
MSFT

Hot Stocks

17:49 EST Microsoft says seeing increased usage of Azure AI by large companies - Seeing larger Azure deals. Seeing strong membership growth on LinkedIn. Comments taken from Q2 earnings conference call.
VRNT

Hot Stocks

17:48 EST Verint Chairman Bodner sells over $2M in company shares - The Chairman of Verint Systems Dan Bodner disclosed the sale of 68,372 shares of company stock at $30 per share on January 26, for a total transaction amount of $2,051,160.
SBUX

Hot Stocks

17:23 EST Starbucks says business and brand in China remain 'strong' - Says occasional customers rebounded in December. Says piloting overnight delivery with GoPuff. Says "deeply distressed" by violence in Middle East. Says business and brand in China remain "strong."
WMT

Hot Stocks

17:13 EST Walmart announces 3-for-1 stock split - Walmart announced that it will conduct a split of its outstanding shares of common stock at a ratio of 3:1. The stock split is part of Walmart's ongoing review of optimal trading and spread levels and its desire for its associates to feel that purchasing shares is easily within reach. More than 400,000 associates participate in Walmart's Associate Stock Purchase Plan today, which allows eligible associates to buy stock conveniently through payroll deductions and provides a 15% company match on the first $1,800 each year. "Sam Walton believed it was important to keep our share price in a range where purchasing whole shares, rather than fractions, was accessible to all of our associates," said Doug McMillon, President and CEO of Walmart. "Given our growth and our plans for the future, we felt it was a good time to split the stock and encourage our associates to participate in the years to come. As Sam said, 'We're all in this together. That's the secret.'"
GOOG GOOGL

Hot Stocks

17:13 EST Alphabet says Vertex AI has seen strong adoption - Says YouTube key driver of subscription revenues. Says found perfect home for NFL Sunday Ticket with YouTube TV. Says Vertex AI has seen strong adoption. Says increase in subscription revenues over the past few years provides strong base. Says AI has been at the core of advertising product for a long time. Says NFL Sunday Ticket helps solidify YouTube's position. Says has gotten really positive feedback. Says pleased with NFL Sunday Ticket sign-ups in first season. Says also allows advertisers to reach football fans and saw solid demand around the offering. Comments taken from Q4 earnings conference call.
SBUX

Hot Stocks

17:12 EST Starbucks says events in Middle East hurt results in U.S. - Says saw "unexpected" headwinds in Q3 which impacted rate of growth. Says remains "very confident" in long-term plans in China. Comments taken from Q3 earnings conference call.
FCF

Hot Stocks

17:07 EST First Commonwealth sees FY24 economic outlook uncertain - "I am proud of the progress we made as a company in 2023. We overcame a very challenging deposit gathering environment, expanded our retail franchise in Central PA and grew within our existing geographies to produce record core EPSof $1.70 with a core pre-tax, pre-provision ROAA of 2.00%," stated T. Michael Price, President and CEO. "While the economic outlook remains uncertain going into 2024, we will remain focused on building on this positive momentum and continuing to live out our mission to improve the financial lives of our neighbors and their businesses."
WAFD LBC

Hot Stocks

17:04 EST Washington Federal receives regulatory approval for Luther Burbank acquisition - WaFd (WAFD) and Luther Burbank (LBC) jointly announced that they received the required regulatory approvals from the Federal Deposit Insurance Corporation and the Washington State Department of Financial Institutions for Luther Burbank Savings to be merged with and into Washington Federal Bank, and from the board of governors of the Federal Reserve System for Luther Burbank to be merged with and into WaFd on the terms and subject to the conditions of the agreement and plan of reorganization, dated as of November 13, 2022, by and between Luther Burbank and WaFd.
LFUS

Hot Stocks

17:04 EST Littelfuse down 5% at $230 after Q4 earnings miss, below-consensus guidance
MYGN

Hot Stocks

17:01 EST Myriad Genetics names George Daneker as Chief Clinical Officer of Oncology - Myriad Genetic "announced the appointment of George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology, effective March 18, 2024. Dr. Daneker brings more than 30 years of oncology and precision medicine experience deeply rooted in providing accessible and equitable oncology care for all patients. In his new role, he will be responsible for leading the commercial and clinical strategy to advance Myriad's oncology portfolio, which currently offers germline testing, tumor profiling and companion diagnostic options, including homologous recombination deficiency testing."
FNV

Hot Stocks

17:01 EST Franco-Nevada raises quarterly dividend 5.88% to 36c per share - Franco-Nevada Corporation announced that its Board of Directors has raised its quarterly dividend and declared a quarterly dividend of 36c per share payable on March 28, 2024 to shareholders of record on March 14, 2024. The increased dividend will be effective for the full 2024 fiscal year. This is a 5.88% increase from the previous 34c per share quarterly dividend and marks the 17th consecutive annual increase for Franco-Nevada shareholders. Canadian investors in Franco-Nevada's IPO in December 2007 are now receiving an effective 12.1% yield on their cost base.
POST

Hot Stocks

17:00 EST Post Holdings CEO Rob Vitale to return from medical leave - Post Holdings "announced that Robert V. Vitale will end his medical leave and continue his full duties as President and Chief Executive Officer, effective January 30, 2024. Jeff A. Zadoks, who has served as interim CEO, will continue his position as Executive Vice President and Chief Operating Officer."
POWL

Hot Stocks

16:57 EST Powell spikes over 13% after Q1 results, dividend boost - Shares of custom-engineered equipment maker Powell spiked 14% in after-hours trading on Tuesday evening to almost $93 per share after the company reported Q1 results that beat on the top and bottom lines by a wide margin. New orders totaled $198M compared to net new orders of $171M and $212M in the fourth and first quarters of Fiscal 2023, respectively. Backlog totaled $1.3B as of December 31 which was essentially flat sequentially compared to backlog as of September 30, and was significantly higher than $680M of backlog as of December 31. Net income was $24.1M, or $1.98 per diluted share, compared to $26.4M, or $2.17 per diluted share, in the fourth quarter of Fiscal 2023 and compared to $1.2M , or 10c per diluted share, in the first quarter of Fiscal 2023.
APOG

Hot Stocks

16:56 EST Apogee expects to incur $16M-$18M of pre-tax charges from Project Fortify - Apogee Enterprises announced strategic actions to further streamline its business operations, enable a more efficient cost model, and better position the company for profitable growth. Project Fortify includes the following strategic changes related to the Architectural Framing Systems segment: Eliminating certain lower-margin product and service offerings, enabling the consolidation of AFS into a single operating entity; Transferring production operations from the Company's facility in Walker, Michigan, to the Company's facilities in Monett, Missouri and Wausau, Wisconsin; and simplifying the segment's brand portfolio and commercial model to improve flexibility, better leverage the Company's capabilities, and enhance customer service. Additionally, the Company will implement actions to optimize processes and streamline resources in its Architectural Services and Corporate segments. "The actions we are announcing today progress our enterprise strategy and help position the Company to build on what we've achieved over the past two years," said Ty R. Silberhorn, Chief Executive Officer. "Project Fortify will further improve our cost structure, enhance organizational efficiency, and enable our team to focus on higher growth, higher margin opportunities." The Company will begin executing these actions immediately and expects to be substantially completed in the third quarter of fiscal 2025. The Company expects to incur approximately $16 million to $18 million of pre-tax charges in connection with Project Fortify, including: $7 million to $9 million of severance and employee related costs; $2 million to $3 million of contract termination costs, and $6 million to $7 million of other expenses. The Company will record these charges as incurred. Any restructuring charges incurred associated with Project Fortify are expected to be adjusted out of GAAP earnings and therefore would not impact adjusted diluted earnings per share for fiscal 2024 or 2025. The actions announced today are expected to lead to annualized cost savings of $12 million to $14 million and reduce the Company's workforce by approximately 250 employees. The Company expects approximately 60% of the savings to be realized in fiscal 2025 and the remainder in fiscal 2026. The Company expects that approximately 70% of the savings will be realized in the AFS segment, 20% in the Architectural Services segment, and 10% in the Corporate segment.
RHI

Hot Stocks

16:54 EST Robert Half down 3% at $78.99 after Q4 results, below-consensus guidance
RHI

Hot Stocks

16:52 EST Robert Half says revenues for first three weeks of January down 17% y/y - The company also states: "For the first four weeks in January, permanent placement revenues were down 25 percent compared to the same period in 2023. 2024 capital expenditures and capitalized cloud computing costs: $90 million to $110 million, with $15M to $20M in the first quarter. Protiviti's first quarter segment income guidance includes the seasonal impact of annual staff promotions and compensation increases, all of which became fully effective on January 1. This produces a sequential decline in midpoint estimated segment margin of 6 percentage points, which is consistent with the 4-7 point decline experienced in most of the last 10 years." Reference Link
MPTI

Hot Stocks

16:51 EST M-Tron Industries to create special strategic committee - M-tron Industries announced that management and its board of directors have created a special independent strategic committee to pursue value enhancing strategies including strategic initiatives to further department of defense engagements, joint ventures, and potential business acquisitions or combination opportunities. MtronPTI continues its commitment to excellence in the Aerospace and Defense, or A&D, end markets. With a rich history of delivering innovative solutions, MtronPTI remains at the forefront of technology, providing mission-critical components and subsystems to enhance the capabilities of high reliability systems. To further this effort, M-tron Industries, seeks to pursue potential M&A activity in the aerospace and defense industry.
POWL

Hot Stocks

16:51 EST Powell announces 1% increase to common stock dividend - Powell announced that Board has approved a 1% increase to common stock dividend for the second consecutive year. "This action demonstrates both our commitment to delivering shareholders' return as well as our prudent approach to capital allocation in order to ensure sufficient liquidity to fund our expanding working capital requirements and growth aspirations," said management.
POWL

Hot Stocks

16:49 EST Powell sees FY24 activity, backlog continuing into FY24 - Commenting on the Company's outlook, Michael Metcalf, Powell's Chief Financial Officer, said, "We are encouraged by the commercial activity across most of our core end markets and optimistic that this will continue throughout the remainder of Fiscal 2024. Considering this, coupled with both the quality and size of our backlog, we are confident that we will sustain the solid financial results that we delivered in Fiscal 2023, and anticipate that this momentum will continue into Fiscal 2024. We also announced today that our Board has approved a 1% increase to our common stock dividend for the second consecutive year. This action demonstrates both our commitment to delivering shareholders' return as well as our prudent approach to capital allocation in order to ensure sufficient liquidity to fund our expanding working capital requirements and growth aspirations."
ABTS...

Hot Stocks

16:46 EST Abits Group produces 43.94 bitcoins in Q4 - Abits Group has released its operations update for the quarter ended December 31, 2023. As previously reported, the company completed the construction of its mining center at Duff, near the city of La Follette in the State of Tennessee in October 2023. The center is deployed with 1180 units of S19XP Hydro miners and 400 units of S19J Pro miners. As of December 31, 2023, the maximum mining hash rate reached 298 PH/s. During the fourth quarter ended December 31, 2023, the Company produced 43.94 bitcoins, including a small contribution of 4.34 bitcoins from its facility in Kazakhstan. Currently, the company is in the process of constructing a new generation of dry-cooler-type hydro containers, which is expected to be completed by the first quarter of 2024. Based on the company's preliminary estimate, upon completion of the project, the hash rate by then could reach up to 340 PH/s.
ALSN

Hot Stocks

16:37 EST Allison Transmission to launch Allison Ventures - Allison Transmission announced it is launching Allison Ventures. Allison Ventures will strategically invest in, and partner with, start-up and growth-stage companies to foster advancements in commercial-duty mobility and work solutions. The team is focused on advancing Allison's global strategy in the ever-evolving mobility market. Allison Ventures is not a separate investment fund but embedded within Allison's corporate team. "Allison Ventures will allow us to increase our innovation pipeline in support of industry technology advancement across commercial-duty mobility and work solutions to further our mission to Improve the Way the World Works," said Todd Bradford, Vice President, Strategy, Business and Corporate Development, Allison Transmission.
NAVI

Hot Stocks

16:36 EST Navient to outsource student loan servicing as part of strategic actions - Navient announced strategic actions to simplify the company and reduce its expense base as a result of the review overseen by the board over the past several months. The strategic actions include outsourcing the servicing of its student loan portfolio to a third party; exploring strategic options for its business processing division-including potential divestment and streamlining the company's corporate functions to align with a simplified business model. Navient has entered into a binding letter of intent that will transition its student loan servicing to Mohela, a provider of student loan servicing for government and commercial enterprises. This transaction is intended to create a variable cost structure for the servicing of the company's student loan portfolio. Navient and Mohel will work toward ensuring a seamless transition in the coming months and providing customers with uninterrupted servicing of their loans. In addition, Navient has launched a process to explore a range of value-creating options for its business processing division. Through various subsidiary brands, this division provides high-quality business processing services for a variety of government and healthcare clients, including hospitals, toll-road authorities, state revenue divisions, and federal agencies. With the decision to outsource student loan servicing, exploring options for the business processing division increases the opportunities for shared cost reduction. Navient is working with financial and legal advisors to assist the company in exploring strategic options for this division, which may include a sale of the division in whole or in part. As it implements these actions, Navient also plans to reshape its shared services functions and corporate footprint to align with the needs of a more focused, flexible and streamlined company. Based on full-year 2023 operating expenses, approximately $400M, which is net of expected outsourced servicing expenses, could be eliminated under a scenario in which the three steps announced were completed. That scenario would also not include business processing revenue under a full-business divestiture scenario. Implementation of these transactions is expected to begin in 2024 and is expected to be largely complete over the next 18 to 24 months.
SYK

Hot Stocks

16:32 EST Stryker jumps 4% to $330 after Q4 earnings beat, above-consensus FY24 guidance
JT

Hot Stocks

16:29 EST Jianpu Technology receives non-compliance letter from NYSE - Jianpu Technology announced that it has received a letter from the NYSE dated January 24, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares, the applicable cure period for the Company to regain compliance will expire on July 24, and with respect to the previous NYSE letter dated September 28, 2023 regarding ADS trading price, the receipt of which was announced by the Company on October 2, 2023, the NYSE confirmed that the Company had regained compliance as of November 30, 2023. Pursuant to NYSE rule 802.01C, a company will be considered to be below compliance standards if the average closing price of a security as reported on the consolidated tape is less than $1.00 over a consecutive 30 trading-day period. Once notified, the company must bring its share price and average share price back above $1.00 within the applicable cure period following receipt of the notification. To address this issue, Jianpu intends to monitor the market conditions of its listed securities and is still considering its options.
MOD

Hot Stocks

16:26 EST Modine Manufacturing: FY24 outlook reflects automotive divestitures in Germany - "We have adjusted our outlook for net sales to reflect the recent automotive divestitures in Germany and to reflect the impact of ongoing market weakness for our heat transfer and heating products," added CEO Brinker. "However, we are once again raising our full-year earnings guidance driven by the strong third quarter results and significant 80/20 progress. Looking longer-term, our business transformation remains in its early stages, and we are either on track or ahead of schedule as we work toward our financial goals."
WTTR

Hot Stocks

16:20 EST Select Water Solutions acquires strategic water infrastructure assets for $90M - Select Water Solutions announced the acquisition of strategic water infrastructure assets in the Haynesville Shale and Rockies regions for approximately $90M of aggregate cash consideration. These acquisitions will add approximately 450,000 barrels per day of permitted disposal capacity to Select's Water Infrastructure segment across 21 active saltwater disposal wells, two slurry injection wells, a solids treatment facility and a number of approved permits for additional recycling and disposal facility development. The active disposal operations are supported by a significant portfolio of interconnected gathering pipelines, strategic surface acreage and right-of-way, and multiple long-term pipeline gathering and dedication contracts.
CNM

Hot Stocks

16:20 EST Core & Main to acquire Dana Kepner Company, terms not disclosed - Core & Main has entered into a definitive agreement to acquire Dana Kepner Company LLC, and associated entities. Dana Kepner is a distributor of water, wastewater, storm drainage, and geotextile products, along with specialty tools and accessories. The acquisition is subject to regulatory approval and other customary closing conditions. "The team at Dana Kepner recognizes the importance of providing local expertise to its customers in the waterworks industry. Like the Core & Main team, they add value by serving as knowledgeable and trusted advisors to municipalities and contractors," said Steve LeClair, chief executive officer of Core & Main. "We are excited about this opportunity to extend our geographic reach, expand the range of products and services that we offer, and add key talent into our organization."
ATKR

Hot Stocks

16:16 EST Atkore initiates quarterly dividend of 32c per share - The dividend is payable on March 15, 2024, to stockholders of record on February 27, 2024.
DELL AVGO

Hot Stocks

16:15 EST Dell delivers Broadcom notice of termination of Commercial Framework Agreement - In a regulatory filing, Dell Technologies (DELL) disclosed that on January 25, the company delivered to Broadcom Inc. (AVGO) written notice of termination of the Commercial Framework Agreement, dated as of November 1, 2021, by and between the company and VMware, Inc. "The Agreement provides that upon a Change in Control of either party, the other party may terminate the Agreement upon 60 days' written notice. A Change in Control of VMware occurred upon the acquisition on November 22, 2023 of VMware's successor, VMware LLC, by Broadcom Inc. The Agreement provides a framework for various commercial activities between the two parties, including how the Company will act as a distributor of VMware products and services as well as how the parties collaborate on certain solutions and go-to-market activities," the filing stated. Reference Link
REAL

Hot Stocks

16:15 EST RealReal names Todd Suko as interim CFO - RealReal previously announced the departure of Robert Julian, Chief Financial Officer, effective January 31, 2024. On January 29, 2024, the Board of Directors of the Company appointed Todd Suko to serve as Interim Chief Financial Officer, effective February 1, 2024, while the Board continues its search for a permanent Chief Financial Officer. Mr. Suko currently serves as the Company's Chief Legal Officer and Secretary and will continue to serve in these capacities while serving as Interim Chief Financial Officer.
MTCH

Hot Stocks

16:15 EST Match Group: Board authorizes new $1B share repurchase program - The company said: "We view capital allocation as an important part of value creation and take a thoughtful approach to balancing investing in our business and returning capital to shareholders. Our Board has authorized a new $1.0 billion share repurchase program and is committed to returning at least half of the company's free cash flow in 2024, and possibly meaningfully more, as was the case in 2023."
MTCH

Hot Stocks

16:14 EST Match Group to roll out many AI-driven features in apps over course of 2024
GOOGL

Hot Stocks

16:10 EST Alphabet Class A shares down 4% after Q4 report - Alphabet Class A shares are down $6.61, or 4%, to $144.85 in after-hours trading.
FBIN

Hot Stocks

16:09 EST Fortune Brands Innovations announces $650M share repurchase authorization - The Company announced that on January 29, 2024, its Board of Directors authorized the repurchase of up to $650 million of shares of the Company's outstanding common stock over the next two years on the open market or in privately negotiated transactions or otherwise, in accordance with applicable securities laws. The $650 million share repurchase authorization announced today is in addition to the $435 million remaining from an existing authorization which expires on March 1, 2024.
ICFI

Hot Stocks

16:09 EST ICF International awarded $33M contract - The U.S. Department of Health and Human Services recently awarded ICF a $33M recompete contract to continue the modernization of the Centers for Medicare and Medicaid system for kidney dialysis data. The contract has a term of three years, including a one-year base and two one-year options.
SBUX

Hot Stocks

16:09 EST Starbucks up 2% at $96.25 after Q1 earnings beat
GOOGL GOOG

Hot Stocks

16:08 EST Alphabet recorded employee severance charges of $2.1B - Alphabet said: "In January 2023, we announced a reduction of our workforce, and as a result we recorded employee severance and related charges of $2.1B for the twelve months ended December 31, 2023. In addition, we are taking actions to optimize our global office space. As a result, exit charges recorded during the three and twelve months ended December 31, 2023, were $1.2B and $1.8B, respectively. In addition to these exit charges, for the three and twelve months ended December 31, 2023, we incurred $62 million and $269 million, respectively, in accelerated rent and accelerated depreciation."
LUXH

Hot Stocks

16:08 EST LuxUrban Hotels tot operate James NoMad Hotel in NYC - LuxUrban Hotels announced that it has signed and funded a 15-year Master Lease Agreement, plus two, five-year options, to operate The James NoMad Hotel in New York City. LuxUrban expects that The James will be rebranded as The J Hotel by LuxUrban, a Wyndham Grand Hotel. The Company expects to take possession of the property and begin welcoming guests on or before March 1, 2024. Boasting an exceptional Beaux-Arts style exterior, the James NoMad is a New York City landmark. This 353-room property - which carries a rating of 4.5 on Tripadvisor - is conveniently located in midtown Manhattan and just a short walk from the Empire State Building, Madison Square Garden and Grand Central Station. Eclectic, post-modern touches define the lobby and works from local artists adorn the walls. The hotel, designed by renowned architect Thomas Juul-Hansen, has been described as an "urban sanctuary."
LC

Hot Stocks

16:08 EST LendingClub sees Q1 loan originations $1.5B-$1.7B
PAYC

Hot Stocks

16:08 EST Paycom names Steve Sturges as Chief Marketing Officer - Paycom Software announced the appointment of Steve Sturges to the role of chief marketing officer. Sturges has spent more than 35 years promoting some of the most influential and successful brands in the country. He co-founded Oklahoma City-based VI Marketing and Branding in 1992 and served as a partner and creative consultant for Paycom for more than 15 years.
SGLY

Hot Stocks

16:08 EST Singularity Future Technology announces 1-for-10 reverse stock split - Singularity Future Technology announced a 1-for-10 reverse stock split of its Common Stock, effective on February 9. Beginning on February 12 , the Company's Common Stock will trade on The Nasdaq Stock Market on a split adjusted basis. Trading in the common stock will continue on the Nasdaq Stock Market under the symbol "SGLY". The new CUSIP number for the common stock following the reverse stock split will be 82935V 307...Upon effectiveness of the reverse stock split, every 10 shares of the Company's issued and outstanding common stock will automatically be converted into one share of issued and outstanding common stock. No fractional shares will be issued as a result of the reverse stock split. Instead, any fractional shares that would have resulted from the split will be rounded up to the next whole number.
GOOGL GOOG

Hot Stocks

16:07 EST Alphabet CFO says ended 2023 with 'very strong' quarter - Ruth Porat, President and Chief Investment Officer; CFO said: "We ended 2023 with very strong fourth quarter financial results, with Q4 consolidated revenues of $86 billion, up 13% year over year. We remain committed to our work to durably re-engineer our cost base as we invest to support our growth opportunities."
SBUX

Hot Stocks

16:06 EST Starbucks reports Q1 global SSS up 5% - In Q1: Global comparable store sales increased 5%, driven by a 3% increase in comparable transactions and 2% increase in average ticket. North America and U.S. comparable store sales increased 5%, driven by a 4% increase in average ticket and 1% increase in comparable transactions. International comparable store sales increased 7%, driven by a 11% increase in comparable transactions and 3% decline in average ticket; China comparable store sales increased 10%, driven by a 21% increase in comparable transactions and 9% decline in average ticket.
GOOGL GOOG

Hot Stocks

16:06 EST Alphabet CEO says 'best is yet to come' entering 'Gemini era' - Sundar Pichai, CEO, said: "We are pleased with the ongoing strength in Search and the growing contribution from YouTube and Cloud. Each of these is already benefiting from our AI investments and innovation. As we enter the Gemini era, the best is yet to come."
GOOGL GOOG

Hot Stocks

16:05 EST Alphabet reports Q4 Google Cloud revenue $9.19B vs. $7.32B last year
GOOGL GOOG

Hot Stocks

16:05 EST Alphabet reports Q4 Google advertising revenue $65.52B vs. $59.04B last year - Reports Q4 Google Search & other revenue $48.02B vs. $42.6B last year. Reports Q3 YouTube ads revenue $9.2B vs. $7.96B last year.
MSFT

Hot Stocks

16:05 EST Microsoft returned $8.4B to shareholders via dividends, buybacks in Q2
HA

Hot Stocks

16:05 EST Hawaiian Holdings sees FY24 CapEx $500M-$550M - Sees FY24 ASMs up 6.0%-9.0%; and CASM up 0.7%-3.0%.
MSFT

Hot Stocks

16:05 EST Microsoft reports Cloud revenue up 24% to $33.7B - "We've moved from talking about AI to applying AI at scale," said Satya Nadella, chairman and CEO of Microsoft. "By infusing AI across every layer of our tech stack, we're winning new customers and helping drive new benefits and productivity gains across every sector." "Strong execution by our sales teams and partners drove Microsoft Cloud revenue to $33.7B, up 24% year-over-year," said Amy Hood, executive vice president and CFO of Microsoft.
DRS NOC

Hot Stocks

16:04 EST Leonardo DRS delivers 1,000th laser system key - Leonardo DRS (DRS) announced that it has delivered the 1,000th Solaris ruggedized laser system that is at the heart of Northrop Grumman's (NOC) Common Infrared Countermeasures system. CIRCM is a next-generation aircraft protection system designed to defend rotary wing, tilt rotor, and small fixed wing platforms across the U.S. armed services from a range of missile threats. "We are proud to be a trusted partner with Northrop Grumman on this critical technology designed to keep aircraft and aircrews out of harm's way," said Dr. Timothy Day, senior vice president and general manager of the Leonardo DRS Daylight Solutions business unit. "This highly reliable technology is designed for the high-threat environment our aircrews face today and tomorrow, and we are pleased to play a part in providing this protection for users across the services."
MSFT

Hot Stocks

16:02 EST Microsoft reports Q2 Xbox content and services revenue up 61% - Reports Intelligent Cloud revenue $25.9B. Reports LinkedIn revenue up 9%.
LYB

Hot Stocks

16:01 EST LyondellBasell and MSI Technology announce agreement - LyondellBasell and MSI Technology announced they have entered into an agreement for MSI Technology to serve the LyondellBasell Polybutene-1, or PB-1, resin line into consumer packaging applications for North America. MSI Technology is also the sales representative for the LyondellBasell Plexar product line. The expansion of the relationship is a strategic fit relative to the markets MSI Technology serves today. MSI Technology will use its technical sales approach combined with its current specialty product portfolio to enhance offerings to customers in consumer packaging. The PB-1 resin line is part of MSI Technology's product offerings. The company also provides clients with access to dedicated sales and technical service specialists who provide guidance on technical resin selection to meet customer requirements.
NOC

Hot Stocks

15:29 EST Northrop Grumman's Cygnus cargo mission successfully launches to ISS - Northrop Grumman Corporation's Cygnus cargo delivery spacecraft was successfully launched to the International Space Station today by SpaceX's Falcon 9 rocket from Space Launch Complex 40 at Cape Canaveral Space Force Station in Florida. This is the company's 20th resupply mission, designated as NG-20. Cyrus Dhalla, vice president and general manager, tactical space systems, Northrop Grumman: "This mission reflects Cygnus's flexibility to launch on a variety of launch vehicles, demonstrating our ability to deliver on our commitments to support NASA's mission. With a decade of experience in cargo and logistics services, Northrop Grumman will continue supporting missions on the International Space Station and future civil and commercial exploration."
ACCO

Hot Stocks

15:08 EST Acco Brands announces three-year restructuring program, to reduce headcount - In a regulatory filing, Acco Brands committed to a three-year restructuring and cost savings program, with anticipated annualized pre-tax cost savings of at least $60M. This includes the annualized savings of $12M related to the previously announced Sidney, New York facility closure. The program incorporates initiatives to simplify and delayer the company's operating structure and reduce costs through headcount reductions, supply chain optimization and global footprint rationalization. The company expects to record a pre-tax restructuring charge for the period ended December 31, 2023 of approximately $13M which is primarily employee termination and benefit costs. This is in addition to the $9M charge previously announced relating to the closure of its Sidney, New York facility. Total cash expenditures are expected to be $26M with cash outflows of $18M in 2024 and $8M in 2025. The Program also includes the company operating and reporting under two segments effective January 1. The two reportable segments will be the Americas and International. The Americas reportable segment includes the U.S., Canada, Brazil, Mexico and Chile. The International reportable segment includes EMEA, Australia, New Zealand, and Asia. The estimates of the charges and expenditures that the company expects to incur in connection with the program, and the timing thereof, are subject to a number of assumptions, and actual amounts may differ materially from estimates. In addition, the company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the Program.
DAL...

Hot Stocks

15:07 EST Delta begins refresh on select Boeing jets, expanding Delta One on Airbus fleet - Delta's (DAL) newest First Class seat will begin rolling out on select refreshed Boeing (BA) 737-800 aircraft this month, the company announced in a post to its corporate news hub. Delta is also expanding the Delta One cabin on its fleet of Airbus (EADSY) A350-900s, the company added. Reference Link
MARK MSFT

Hot Stocks

14:02 EST Remark Holdings says $80M initial partnership with Microsoft 'official' - Remark Holdings tweeted: "It's official!!! @Microsoft making #RemarkAI global together - $80 million dollar initial partnership @Azure #ComputerVision #AI $MARK - Just in time for #SuperBowl2024." The company said in another tweet: "Looking forward to partnering with @Microsoft @Azure on #RemarkAI #computervision #largevisionmodels globally. This includes the videos showcased here on our government projects which includes NYC, LA, Miami, UK, Spain and Saudi Arabia $MARK" Reference Link
MMS LDOS

Hot Stocks

13:02 EST Maximus names Derrick Pledger as Chief Digital and Information Officer - Maximus (MMS) announced Derrick Pledger has been named Chief Digital and Information Officer, or CDIO. "In this new role, Pledger will lead the company's technology modernization and enterprise IT strategies to spur growth while delivering seamless customer experience and improved service delivery for government agencies... He joins Maximus after serving as CDIO at Leidos, where Pledger successfully led a global team of technologists, developers, enterprise architects, and service delivery experts responsible for managing a digital ecosystem supporting more than 47,000 employees," the company stated.
JWN

Hot Stocks

13:01 EST Nordstrom Rack to open two new locations in North Carolina - Nordstrom announced plans to open two new Nordstrom Rack stores in North Carolina. The new stores will be located in Raleigh and Matthews, which will open in fall 2024 and spring 2025, respectively. "We look forward to being a part of the Raleigh and Matthews communities and serving our customers with an amazing offering of great brands at great prices," said Gemma Lionello, President of Nordstrom Rack Stores. "We're excited to grow our footprint in these regions and introduce new customers to the Nordstrom experience." Lionello added that in these new locations, "customers will be able to take advantage of our convenient services such as online order pick up from both Nordstrom.com and NordstromRack.com, and they can make returns easily."
VNDA

Hot Stocks

12:38 EST Court orders FDA to resolve Vanda's jet lag hearing request by March 4 - Vanda Pharmaceuticals announced that the United States District Court for the District of Columbia granted Vanda's motion for summary judgment on its claim against the United States Food and Drug Administration for unlawfully delaying a hearing on the approvability of Vanda's supplemental new drug application for HETLIOZ to treat jet lag disorder. Vanda submitted its sNDA in October 2018 for approval to market HETLIOZ to treat jet lag disorder. The FDA did not comply with the statute and did not timely approve or provide an opportunity for a hearing. Instead, the FDA issued a complete response letter in August 2019. Vanda said "The Court's decision highlights the serious flaws in FDA regulations governing drug-approval processes, and it reinforces the FDA's clear statutory obligations to render timely final decisions on drug applications. It appears from this case, and from the FDA's standard policies, that FDA decisionmakers have implemented a policy of following the FDA's own timelines, resulting in unlawful actions that are systemic. The FDA's extraordinary delays impede medical innovation to the detriment of the many patients with unmet needs who lack effective therapeutics. The FDA's delays force these patients to wait years longer than Congress envisioned for access to urgently needed pharmaceutical innovation."
AGR

Hot Stocks

12:32 EST Avangrid announces onshore wind project in Oklahoma - Avangrid announced its first renewable energy project in Oklahoma. Pontotoc Wind, a 147.5 MW wind farm with 33 turbines, powering 40,000 homes, will be constructed in Pontotoc County, Oklahoma and expand Avangrid's presence in the U.S. to 25 states. "We are thrilled to be developing our first renewable energy project in Oklahoma, that will deliver clean, renewable, wind power to the Pontotoc County community along with jobs and local investment," said Pedro Azagra, Avangrid CEO. "With Pontotoc Wind, we are helping to accelerate a clean energy transition in the state and across the U.S." Pontotoc Wind will generate about 500,000 MWh of power each year, enough energy to power more than 40,000 homes.
ATGE

Hot Stocks

12:22 EST Adtalem Global Education to announce Q2 results after the market close Tuesday - Adtalem Global Education announced that it will release its fiscal 2024 second quarter results, ahead of schedule, on Tuesday, January 30, 2024, after financial markets close. The company's earnings announcement was originally scheduled for Thursday, February 1, 2024. In light of market news today, Adtalem has rescheduled its earnings announcement to provide a timely update on the company's performance and guidance.
TROW

Hot Stocks

12:10 EST T. Rowe Price raises quarterly dividend to $1.24 from $1.22 per share - T. Rowe Price Group declared a quarterly dividend of $1.24 per share payable March 28, to stockholders of record as of the close of business on March 15. The quarterly dividend rate represents a 1.64% increase over the previous quarterly dividend rate of $1.22 per share. "This will mark the 38th consecutive year since the firm's initial public offering that the company will have increased its regular annual dividend," it said in a statement.
RDW

Hot Stocks

12:02 EST Redwire opens new manufacturing facility in Longmont, Colorado - Redwire Corporation announced today the opening of the company's new manufacturing facility in Longmont, Colorado. The new Longmont facility features 26,000 square feet of high-bay manufacturing, integration, and testing floor space as well as an advanced RF testing chamber for installed performance testing of RF payloads. With the new facility, Redwire is expanding its footprint in Longmont by 70 percent, bringing the total workable area to just under 65,000 square feet. This cutting-edge facility will enable further high-volume design, manufacturing, and testing of a variety of space-based antenna hardware and large-scale deployable structures for use in low-Earth orbit and beyond for government and commercial customers.
BORR

Hot Stocks

12:01 EST Borr Drilling falls -9.2% - Borr Drilling is down -9.2%, or -68c to $6.70.
ATGE

Hot Stocks

12:01 EST Adtalem Global Education falls -22.8% - Adtalem Global Education is down -22.8%, or -$13.38 to $45.26.
CALX

Hot Stocks

12:00 EST Calix falls -26.9% - Calix is down -26.9%, or -$11.93 to $32.42.
CPS

Hot Stocks

12:00 EST Cooper-Standard rises 8.8% - Cooper-Standard is up 8.8%, or $1.51 to $18.64.
MSCI

Hot Stocks

12:00 EST MSCI rises 11.5% - MSCI is up 11.5%, or $63.43 to $614.38.
HP

Hot Stocks

12:00 EST Helmerich & Payne rises 16.5% - Helmerich & Payne is up 16.5%, or $6.00 to $42.26.
WMB

Hot Stocks

11:38 EST Williams increases quarterly cash dividend 6.1% to 47.50c per share - Williams' board of directors has approved a regular dividend of 47.50c per share, or $1.90 annualized, on the company's common stock, payable on March 25, 2024, to holders of record at the close of business on March 8, 2024. This is a 6.1% increase from Williams' fourth-quarter 2023 quarterly dividend of 44.75c per share, paid in December 2023. Some portion of this distribution may be considered a return of capital for tax purposes.
PEPG

Hot Stocks

10:59 EST PepGen Inc trading resumes
PEPG

Hot Stocks

10:49 EST PepGen Inc trading halted, volatility trading pause
JBLU

Hot Stocks

10:26 EST JetBlue making buyout offers to some workers to cut costs
JBLU RTX

Hot Stocks

10:22 EST JetBlue in negotiations with Pratt & Whitney about compensation
SYY

Hot Stocks

10:21 EST Sysco remains on track to grow free cash flow for FY24 - Says capital allocation is a competitive advantage for Sysco. Expects both top- and bottom-line growth in 2024. Says balance sheet remains strong. Says committed to capital allocation strategy. Expects to win market share profitably and consistently.
JBLU

Hot Stocks

10:19 EST JetBlue currently has 7 aircraft parked due to GTF engine issues
JBLU

Hot Stocks

10:17 EST JetBlue sees y/y revenue growth 'much stronger' in 2H24
SYY

Hot Stocks

10:13 EST Sysco expects 'positive momentum' to continue into 2H24 - Says expects to buyback $1.25B of stock in 2024, up from $750M. Says playing from a position of strength. Says grew market share profitably in Q2. Says remains solidly on track to deliver on growth ambitions. Says focused on improving sales execution. Says refined compensation model, can see the impact of the compensation change. Says focus on performance management continues. Says total team selling continues to gain traction. Says confident in ability to continue to grow local sales. Says continues to improve performance of supply chain. Says focused on continuing to improve colleague retention and performance in supply chain. Says remains on track with Recipe for Growth business transformation. Says FY24 off to a 'strong' start.
JBLU SAVE

Hot Stocks

10:07 EST JetBlue evaluating options under merger agreement with Spirit, says Hayes
JBLU SAVE

Hot Stocks

10:07 EST JetBlue 'strongly disagrees' with court ruling on Spirit merger, says Hayes
JBLU SAVE

Hot Stocks

10:06 EST JetBlue 'not in a position' to discuss Spirit merger agreement, says Hayes
JBLU

Hot Stocks

10:06 EST JetBlue's outgoing CEO 'confident about next phase of our evolution' - Comments taken from Q4 earnings conference call.
RTC

Hot Stocks

10:05 EST Baijiayun Group Ltd trading resumes
CZR

Hot Stocks

10:04 EST Caesars to offer mobile sports betting throughout North Carolina - Caesars Entertainment announced an expansion of its relationship with the Eastern Band of Cherokee Indians to bring the company's sports wagering platform online in the Tar Heel State for the launch of legalized mobile sports wagering. "The agreement furthers the partnership, granting Caesars Sportsbook with mobile sports betting market access via a license held by the Eastern Band of Cherokee Indians Tribal Casino Gaming Enterprise, subject to all required regulatory approvals. Caesars Sportsbook intends to go live with mobile sports wagering when North Carolina launches online sports betting on March 11, 2024. Ahead of the official launch, the Caesars Sportsbook mobile app will begin accepting sign-ups and deposits starting on March 1," Caesars stated.
SYY

Hot Stocks

10:00 EST Sysco expects to maintain a net debt to adjusted EBITDA ratio of 2.5x-2.75x - Sees capital investments in technology, fleet, buildings. Targeting 50-100 bps of growth annually from M&A; integration of Edward Don business progressing as planned. Says strong pipeline of tuck-in acquisitions focused on Broadline, Specialty and Cuisine-Type opportunities as well as underpenetrated markets in U.S., UK and Canada. Says 96% of debt fixed at attractive rates. Says committed to dividend aristocrat status. Comments taken from Q2 conference call investor presentation.
CPS

Hot Stocks

10:00 EST Cooper-Standard rises 8.2% - Cooper-Standard is up 8.2%, or $1.40 to $18.53.
RTC

Hot Stocks

10:00 EST Baijiayun Group Ltd trading halted, volatility trading pause
GM

Hot Stocks

10:00 EST General Motors rises 9.2% - General Motors is up 9.2%, or $3.26 to $38.65.
HP

Hot Stocks

10:00 EST Helmerich & Payne rises 11.2% - Helmerich & Payne is up 11.2%, or $4.07 to $40.33.
BORR

Hot Stocks

10:00 EST Borr Drilling falls -11.4% - Borr Drilling is down -11.4%, or -84c to $6.54.
ATGE

Hot Stocks

10:00 EST Adtalem Global Education falls -15.1% - Adtalem Global Education is down -15.1%, or -$8.86 to $49.77.
CALX

Hot Stocks

10:00 EST Calix falls -26.6% - Calix is down -26.6%, or -$11.81 to $32.54.
WNW

Hot Stocks

09:57 EST Meiwu Technology Co Ltd trading resumes
NEXI

Hot Stocks

09:57 EST Neximmune Inc trading resumes
WNW

Hot Stocks

09:52 EST Meiwu Technology Co Ltd trading halted, volatility trading pause
NEXI

Hot Stocks

09:52 EST Neximmune Inc trading halted, volatility trading pause
ALRN

Hot Stocks

09:51 EST Aileron Therapeutics trading resumes
BORR

Hot Stocks

09:47 EST Borr Drilling falls -12.3% - Borr Drilling is down -12.3%, or -91c to $6.47.
ATGE

Hot Stocks

09:47 EST Adtalem Global Education falls -17.3% - Adtalem Global Education is down -17.3%, or -$10.12 to $48.51.
CALX

Hot Stocks

09:47 EST Calix falls -26.4% - Calix is down -26.4%, or -$11.71 to $32.64.
AKA

Hot Stocks

09:47 EST a.k.a. Brands rises 7.4% - a.k.a. Brands is up 7.4%, or 73c to $10.57.
MSCI

Hot Stocks

09:47 EST MSCI rises 7.5% - MSCI is up 7.5%, or $41.29 to $592.24.
GM

Hot Stocks

09:47 EST General Motors rises 8.0% - General Motors is up 8.0%, or $2.82 to $38.21.
ALRN

Hot Stocks

09:46 EST Aileron Therapeutics trading halted, volatility trading pause
NVVE

Hot Stocks

09:34 EST Nuvve Holding partners with e-Formula for V2G hub project in Taiwan - Nuvve Holding Corp, in collaboration with e-Formula announce the potential to launch the first V2G hub project in Taiwan. e-Formula would serve as the project lead for this 95 EV V2G Hub project, and Nuvve is expected to be the technical project manager and service provider. Nuvve currently anticipates completion of contract negotiation for this project in March, with underlying business assumptions allowing for Nuvve to deploy a mix of unidirectional and bidirectional charging stations ranging from 11kW to 150kW. Nuvve will contract with Taipower to be compensated for grid services through the combination of EVSEs provided by Nuvve and stationary storage provided by e-Formula. By combining Nuvve's world-class V2G technology with e-Formula's extensive experience in energy solutions, this project would set a new standard for sustainable urban transit.
TIVC

Hot Stocks

09:32 EST Tivic Health enters distribution agreement with medical product distributor - Tivic Health Systems entered a limited exclusive distribution agreement with one of the Top 10 Medical Equipment Distributors and Suppliers in the nation. Under the terms of the agreement, the new Distributor will have certain exclusive distribution rights for Tivic Health's ClearUP product for Walmart, Target, eBay and Kroger, as well as non-exclusive distribution rights in other specified on-line channels.
MULN

Hot Stocks

09:31 EST Mullen Automotive announces vehicle order with Grupo Cavel - Mullen Automotive announced a vehicle order with Grupo Cavel to purchase Mullen CAMPUS EV cargo vans for sale in the Dominican Republic and Caribbean markets via Cavel's Electric Motors dealerships. Mullen CAMPUS EV cargo vans are currently distributed through Mullen's retail dealership partner, Randy Marion Automotive Group. Grupo Cavel's first vehicle order includes 20 CAMPUS EV cargo vans, which will be sold via its Electric Motors dealership group. Cavel plans to continue ongoing vehicle orders and will be establishing a sales and service distribution channel for Mullen's lineup of commercial EVs in the Dominican Republic and Caribbean.
UPS AMZN

Hot Stocks

09:27 EST UPS says Amazon.com accounted for 11.8% of revenue in 2023
PALI

Hot Stocks

09:27 EST Palisade Bio exercises previously issued warrants fo $2.5M - Palisade Bio announced an agreement between the Company and several accredited investors to exercise certain existing warrants to purchase up to an aggregate of 3,413,286 shares of common stock. The Existing Warrants had initial exercise prices of $35.525, $2.375, and 2.64, respectively, and were issued by the Company on May 10, 2022, January 4, 2023, and April 5, 2023, respectively, with each exercise occurring at a reduced exercise price of $0.7313 per share. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to registration statements which were filed and declared effective by the Securities and Exchange Commission. The gross proceeds to the Company from the exercise of the Existing Warrants are expected to be approximately $2.5 million prior to deducting placement agent fees and estimated offering expenses. In consideration for the immediate exercise of the Existing Warrants for cash, the exercising holders will receive new unregistered warrants to purchase shares of common stock in a private placement pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. The Replacement Warrants will be exercisable into an aggregate of up to 3,413,286 shares of common stock, at an exercise price of $0.7313 per share, and a term of exercise equal to five years from issuance. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. Ladenburg Thalmann & Co. Inc. acted as the exclusive placement agent for the warrant exercise transaction.
UPS

Hot Stocks

09:26 EST UPS says pricing environment 'very rational' - Says volume decline "heavily weighted" in Europe. Says drama in Red Sea causing "a lot of chaos."
CYCC

Hot Stocks

09:20 EST Cyclacel terminates CMO Kirschbaum, appoints Schwartz as interim CMO - Cyclacel Pharmaceuticals announced that Brian Schwartz, M.D. will assume the role of interim Chief Medical Officer, CMO, of the Company effective immediately. Dr. Schwartz will succeed Mark Kirschbaum, M.D., whose employment was terminated by the Company. Dr. Schwartz has served as a member of the board of directors of the Company since December 2020.
CCL

Hot Stocks

09:18 EST Carnival reroutes Red Sea transits - Carnival has been actively monitoring the situation in the Red Sea and surrounding region and given recent developments and in close consultation with global security experts and government authorities, has made the decision to reroute itineraries for 12 ships across seven brands, which were scheduled to transit the Red Sea through May 2024. The Red Sea rerouting is expected to have an adjusted EPS impact of 7c-8c for full year 2024, with the vast majority of the impact in Q2. The company has not seen an impact on booking trends due to the Red Sea situation and has no other Red Sea transits until November 2024. For 2024, the company continues to have the best booked position on record, with both pricing and occupancy considerably higher than 2023 levels. In fact, the first half of 2024 is almost fully booked. In addition, the company redeemed the outstanding $571M, 9.875% second-priority senior secured notes due 2027, eliminating all of the remaining second lien debt outstanding.
PSNL

Hot Stocks

09:18 EST Personalis and ClearNote announce partnership to 'advance' epigenomic tech - Personalis and ClearNote Health unveiled an alliance through which Personalis will expand its pharmaceutical service offerings by distributing ClearNote's cutting-edge epigenomic 5-hydroxymethylcytosine or 5hmC, platform. "We have built a unique pharma channel based on our industry-leading tissue and MRD assays and ClearNote Health's blood-based epigenomic approach is complementary to our offering as it helps our customers deepen their understanding of a patient's response to immunotherapies," said Chris Hall, CEO and President of Personalis. "Commercial partnerships such as this broaden our portfolio and are expected to appeal to a wide range of biopharma customers and accelerate our revenue growth." Echoing this sentiment, Dave Mullarkey, CEO of ClearNote Health, remarked, "Partnering with Personalis presents an excellent opportunity to bring our 5hmC technology to the forefront of cancer research. This alliance is a testament to the synergy between our two companies, enabling us to expand our reach and significantly impact the biopharmaceutical industry. Together, we can accelerate the development of personalized therapies and make a real difference in the lives of patients."
SON

Hot Stocks

09:17 EST Sonoco to divest Protective Solutions business to Black Diamond for $80M - Sonoco Products Company announced that certain of its subsidiaries entered into a definitive agreement to sell its Protective Solutions business to Black Diamond Capital Management for an estimated $80 million in cash. The transaction is subject to customary closing conditions and is expected to be completed in the first half of 2024. This sale is the result of Sonoco's continuing evaluation of its business portfolio and is consistent with its strategic and investment priorities. Sonoco's Protective Solutions business is one of North America's premier manufacturers of molded expanded polypropylene and expanded polystyrene foam components and integrated material solutions serving the automotive, power sports, impact surfaces, HVAC, electronics/technology, appliances, and various other industrial end markets. The business operates nine manufacturing facilities and has approximately 900 employees. Net sales were approximately $170 million in 2023. Financial results for Protective Solutions are reported in Sonoco's All Other Businesses reporting segment.
TYGO

Hot Stocks

09:15 EST Tigo: USPTO rules in favor of Tigo on 2 petitions previously filed by SMA Solar - Tigo Energy announced that in a patent infringement case filed by Tigo against SMA Solar Technology America the U.S. Patent and Trademark Office USPTO has ruled in favor of Tigo on two petitions previously filed by SMA Solar. In the failed IPR petitions, SMA Solar sought a ruling from the USPTO to invalidate Tigo U.S. Patents Nos. 9,966,848 and 10,333,405 . Tigo continues to defend the Company's intellectual property as part of an infringement complaint brought by Tigo against SMA Solar, which remains pending in the District of Delaware under case number 22-915-GBW. In the pending patent infringement lawsuit, Tigo alleges infringement by SMA Solar on Tigo innovations in power supplies for module-level power electronics, MLPE , including those used in the Tigo TS4 product line. On January 12 and January 22, the USPTO denied the SMA petitions for IPRs related to the '405 and '848 patents. The complaint is focused on various systems and methods used in module-level power electronics that are attached to photovoltaic PV panels..."The ability to protect and defend intellectual property is central to protecting the investments companies make in R&D and to maintaining the spirit of innovation that makes nations competitive," said Zvi Alon, CEO at Tigo Energy. "This decision by the USPTO is positive reinforcement of the validity of the pending case before the jurists, and Tigo is confident in its ability to protect the intellectual property that underpins our world-class technology."
AMIX

Hot Stocks

09:13 EST Autonomix regains exclusive worldwide rights to technology for cardiology field - Autonomix Medical announced that it has regained exclusive worldwide rights to its technology for cardiology field use from Impulse Medical. "We have made significant progress over the course of the past year. With the recent closing of our IPO and listing onto Nasdaq as well as the progress we've made on the preclinical development front, we continue to build momentum. Regaining the cardiology rights to our innovative technology broadens our development opportunities and provides further optionality related to our development strategy moving forward. Looking ahead, we remain focused on our pancreatic cancer pain development program and are on track to commence our first-in-human clinical study this quarter," commented Lori Bisson, Chief Executive Officer of Autonomix.
CART

Hot Stocks

09:13 EST Instacart expands online SNAP acceptance for same-day grocery delivery - Instacart announced a series of retail expansions that will allow customers to use Supplemental Nutrition Assistance Program - SNAP - benefits to shop online for groceries for same-day delivery from Food City, Gordon Food Service, Hy-Vee, Schnucks, and additional Kroger banners. The new retail expansions help make groceries more accessible to more SNAP families, allowing them to save time and maximize their budgets. Instacart now offers online SNAP acceptance from more than 170 retail banners spanning more than 14,000 stores, reaching 96% of SNAP households in the U.S.
UPS

Hot Stocks

09:11 EST UPS sees positive U.S. daily volume growth in 2H24 - Expects higher labor costs in 1H24. Says capital allocation strategy remains unchanged. Says 75% of 12,000 headcount reduction to occur in 1H24. Says job cuts are 14% of approximately 85,000 management positions.
SYF

Hot Stocks

09:11 EST Synchrony partners with PatientNow for payment technology in cosmetic industry - Synchrony and PatientNow, a practice management company for the elective medical industry, announced a partnership that will combine technology, products and resources from both companies to transform payments and simplify work across cosmetic practices and the medical spa industry. The CareCredit health and wellness credit card is now integrated as one of the primary financing options in the PatientNow cloud-based practice management solution across PatientNow's 4,800 aesthetic and cosmetic businesses nationwide. The CareCredit integration into PatientNow's Practice Management Software will enable cosmetic practices to offer a variety of customized financing options to their patients, enhanced account management solutions and marketing capabilities. Synchrony and PatientNow will also partner to incorporate new digital features.
RVSN

Hot Stocks

09:11 EST Rail Vision reveals next generation AI computer for railway safety - Rail Vision announces its next generation AI- based computer to be incorporated in its Main Line and Switch Yard systems. This advanced system represents a major evolution from the Company's existing AI-based solutions, featuring advanced real-time deep learning capabilities and compliance with stringent railway standards. "Rail Vision's next-generation AI computer system, is a significant milestone in railway safety technology. This innovation embodies our unwavering commitment to advancing railway security, marrying cutting-edge AI with real-time processing to prevent accidents and save lives. Our system, technology and cloud connectivity are transformative leap forward, marking a new chapter in intelligent railway operations", said Shahar Hania, Rail Vision's Chief Executive Officer.
TTEK

Hot Stocks

09:10 EST Tetra Tech selected for GBP 100M framework to improve water quality in UK - Tetra Tech announced that United Utilities, one of the United Kingdom's largest listed water companies, selected Tetra Tech for a GBP 100M single-award framework to support the improvement of river health across the North West of England. Under this 10-year framework, Tetra Tech engineers and scientists will drive program optimization, develop solutions and select the preferred options based on best value, lowest carbon and cost.
EEFT...

Hot Stocks

09:10 EST Euronet announced a multi-year agreement with Banco Guayaquil - Euronet (EEFT) announced a multi-year agreement with Banco Guayaquil, that begins with revolutionizing the transaction-switching solutions for VISA (V), MasterCard (MA) and American Express (AXP) within the bank's broad network. Central to this agreement is the deployment of Euronet's Ren payments platform and its advanced Software as a Service model that will enhance compliance, operational uptime and technology adaptability at the bank, impacting millions of cards and overseeing millions of transactions monthly. As part of the initial switching and future projects, Ren will provide the following benefits to the bank during the partnership: Phased Migration and Zero-Downtime Transition. Compliance and Uptime Improvements. Adoption of Open Banking and New Technologies.
VRNS

Hot Stocks

09:10 EST Varonis announces universal data classification support for databases - Varonis Systems announced the ability to integrate with connected databases hosted in the cloud or on-premises, building on its existing support for popular databases such as Oracle, SQL Server, MySQL, and PostgreSQL. This new universal database connector lets Varonis rapidly integrate with virtually any modern DBMS, allowing customers to use Varonis' vast library of classifiers and scalable architecture to centralize data classification efforts in a single, unified platform.
GLT

Hot Stocks

09:09 EST Glatfelter enters partnership with Tzuriel - Glatfelter Corporation announced its growing partnership with Tzuriel, am importer and exporter of specialty products based in Pinhais, Brazil. This collaboration marks a significant step in advancing the Sontara brand in Latin America. Tzuriel, known for its extensive experience and technical expertise in various specialty markets, will be supporting Sontara's sales and distribution efforts in South America. The partnership includes the distribution of Sontara materials across the region, tapping into Tzuriel's well-established network and logistics capabilities.
SYRA

Hot Stocks

09:08 EST Syra Health wins new contract from Arizona's Maricopa County Health Department - Syra Health announced another contract win from the Maricopa County Department of Public Health to provide public health training. Under the new agreement, Syra Health will deliver its Foundations of Public Health training to employees of the Maricopa County Department of Public Health as well as community-based organizations. The goal of the training is to advance public health awareness. The customized training provided by Syra Health's public health experts will include information about the historical evolution of public health, the importance of public health and health equity, public health influences, and how to impact public health positively. The training will also include the role of public health departments and how to collaborate with those departments. This is the second contract awarded to Syra Health by Maricopa County for healthcare training.
MODN

Hot Stocks

09:08 EST Model N launches price management to help streamline pricing - Model N has launched Price Management, a new solution that enables semiconductor, electronic component, and high-tech manufacturers to manage price execution across direct and channel sales teams globally. Fully integrated with Model N Deal Management, Price Management streamlines pricing updates to reduce the effort required to keep prices current and consistent - enabling tight pricing control and seamless market execution. "Model N has directly seen the challenges high-tech manufacturers experience in executing and updating complex pricing models across markets," said Suresh Kannan, chief product officer at Model N. "Model N's new Price Management solution fills a market gap by equipping our customers with greater pricing control, speed, and flexibility that leads to revenue optimization and profitability. Integrated with Model N's Deal Management, Price Management distinguishes Model N as the leader in revenue cloud applications for high-tech companies."
TALK

Hot Stocks

09:06 EST Talkspace, Bicycle Health partner to expand access to virtual care - Talkspace and Bicycle Health announced plans for a partnership to expand their respective patients' access to virtual care. For Talkspace patients, this partnership increases access to OUD specialty care - specifically, medication for opioid use disorder treatment, MOUD, as well as therapists and recovery coaches who specialize in treatment of OUD. For Bicycle Health patients, this partnership increases access to therapists specializing in areas outside of substance use disorder, including marriage and family therapy, and asynchronous therapeutic chat. "Opioid use disorder does not exist in a vacuum. We consider the whole person and their environment when recommending the right care plan to help them achieve stable, lasting recovery," said Dr. Brian Clear, Chief Medical Officer at Bicycle Health. "Like patients in all care settings, Bicycle Health patients often experience depression, anxiety, or other behavioral conditions beyond their addiction, and many will benefit from a relationship with a therapist at Talkspace with expertise to meet their needs. Now, in addition to our own internal therapist team, our clinicians have the ability to connect our patients to a therapist at Talkspace quickly and reliably whenever that's the right choice for any patient."
D

Hot Stocks

09:06 EST Dominion receives two last federal approval for Coastal Virginia wind project - Dominion has received the last two major federal approvals needed to begin construction of its 2.6-gigawatt Coastal Virginia Offshore Wind - CVOW -, keeping the largest offshore wind farm in the United States on schedule to generate enough clean, renewable energy to power up to 660,000 homes once fully constructed in late 2026. The Bureau of Ocean Energy Management provided its final approval of CVOW's Construction and Operations Plan, which authorizes construction offshore. The U.S. Army Corps of Engineers issued its permit to allow for permitted impacts to U.S. waters, including the route of the electric transmission line that will connect the clean, renewable energy generated offshore to the electric grid onshore. More than 750 Virginia-based workers - nearly 530 in theHampton Roadsregion - have been engaged on the CVOW project or with other businesses supporting CVOW. More than 1,000 local jobs will be needed to support ongoing operations and maintenance of this facility after the project begins commercial operation. Initial offshore construction activities related to the export cable and the monopile foundation installation is expected to begin in Q2 of this year.
UDMY NOW

Hot Stocks

09:05 EST ServiceNow integrates Udemy 'Power Skills' course into Now Learning - Udemy (UDMY) and ServiceNow (NOW) announced that more than 75 of Udemy's "power skills'' courses will be integrated into ServiceNow's Now Learning platform to complement existing technology training. Through this first-of-its-kind partnership, Now Learning, the training and certifications component of the RiseUp with ServiceNow initiative to skill one million people on the Now Platform, will offer an even more comprehensive "power skills'' training program by blending in-demand soft skills like communication, collaboration and analytical thinking courses with traditional technical competencies.
LCID

Hot Stocks

09:04 EST Lucid Group names Matt Everitt as General Counsel - Lucid Group is pleased to announce the appointment of Matt Everitt as General Counsel. Everitt joins Lucid after 12 years at Mercedes-Benz, where he held several leadership roles in both the U.S. and Germany, most recently as General Counsel of Mercedes-Benz North America.
NEXN

Hot Stocks

09:03 EST Nexxen appoints Johnson as Chief People Officer - Nexxen announced the appointment of Gretchen Johnson as Chief People Officer. In the role, Johnson will lead Nexxen's Human Resources and Talent Acquisition teams, focusing on culture and employee development to ensure the company continues to hire and retain best-in-class talent. Previously, Johnson served as Chief People Officer at Siprocal.
GM

Hot Stocks

09:02 EST General Motors 'committed' to Cruise, technology is 'sound,' says CEO
IBEX

Hot Stocks

09:02 EST Ibex launches Wave iX AI-driven customer experience solution suite - ibex introduced Wave iX, the definitive AI-driven digital-first customer experience and employee experience solution suite. Wave iX seamlessly integrates innovative AI-powered solutions with ibex's cutting-edge CX platform to facilitate advanced, hyper-personalized, and intelligent interactions that cultivate stronger connections between brands and their customers.
AJG

Hot Stocks

09:01 EST Arthur J. Gallagher acquires Horak Insurance - Arthur J. Gallagher acquired Washington, Iowa-based Horak Insurance. Terms of the transaction were not disclosed. Horak Insurance is a retail property/casualty insurance agency serving commercial and personal lines clients as well as farms in eastern and central Iowa. Paul Horak, Luke Horak and their team will remain in their current locations under the direction of Ryan Isaacs, head of Gallagher's Midwest region retail property/casualty brokerage operations.
GM

Hot Stocks

08:59 EST General Motors sees slight Q1 loss in China, CFO says
CLF...

Hot Stocks

08:59 EST Cleveland-Cliffs sees FY24 capital expenditures $675M-$725M - Cleveland-Cliffs (CLF) sees FY24 capex similar to FY23 . Sees $500M benefit to FY24 adjusted EBITDA from cost reductions. Sees FY24 steel shipments 16.5M net tons. Says was company D in stated proxy files by U.S. Steel (X) last week. Says Nippon Steel (NPSCY) acquisition of U.S. Steel has uncertain path to close. Says M&A deals invloving unions and labor agreements are not cookie cutter. Says Cleveland-Cliffs' final proposal valued U.S. Steel at $60 per share. Says offer included remedies to decrease antitrust regulatory risk. Says current deal with Nippon has political risks given supply chain and national security. Says generated more cash in 2023 than in 2022 despite lower EBITDA. Says plans to be even more aggressive with share buybacks. Says buybacks are the number one priority going forward. Comments and guidance taken from Q4 earnings conference call.
LPLA

Hot Stocks

08:56 EST Community Resource Credit Union partners with TruStage - TruStage announced an agreement to provide Community Resource Credit Union and CRCU Retirement and Investment Services, CRCU's wealth management arm, with a powerful combination of TruStage and the investment and wealth management services of LPL Financial. CRCU Retirement and Investment Services advisors serve approximately $175 million in advisory, brokerage and retirement plan assets. The relationship between TruStage, LPL Financial, CRCU and CRCU Retirement and Investment Services allows their advisors to offer more members access to personalized wealth management advice and comprehensive planning services.
GM

Hot Stocks

08:55 EST GM sees 2024 market similar to 2023, sees total U.S. industry volumes 16M units
JAGX FLHLF

Hot Stocks

08:52 EST Magdalena Biosciences announces results from preclinical study in mice in Brazil - Jaguar Health (JAGX) announced that a preclinical study in mice initiated in Brazil by Magdalena Biosciences, the joint venture recently formed by Jaguar and Filament Health Corp. (FLHLF) to develop novel, natural prescription medicines derived from plants for mental health indications, indicates psychoactive activity in a plant extract in a lead Magdalena botanical drug candidate. The botanical drug candidate is being evaluated for its potential use as a next-generation psychoactive prescription drug for treatment of mental health conditions such as attention-deficit/hyperactivity disorder, depression, anxiety, and other possible neuropsychiatric conditions. The evaluation process for plants that have a history of traditional use by humans involves expanding traditional uses with exploratory studies in animals prior to initiating clinical trials in people. To this end, mice experiments with this extract of the Magdalena lead botanical drug candidate have shown increased brain metabolism that indicate its potential beneficial effect for several conditions where such areas show hypofunction, including ADHD, depression, and anxiety. Moreover, the connectivity analysis demonstrated that this plant extract appears to beautifully reshape the neuronal network. The Magdalena preclinical study consisted of radioactive fluorodeoxyglucose positron emission tomography scans performed by Dr. Daniella Faria, Faculdade de Medicina da Universidade de Sao Paulo, with the analysis done by Dr. Eduardo A. Zimmer through his consultancy.
LEXX

Hot Stocks

08:50 EST Lexaria Bioscience submits IND application to FDA for DehydraTECH-CBD trial - Lexaria Bioscience submitted its Investigational New Drug application with the U.S. Food and Drug Administration for its planned U.S. phase 1b hypertension clinical trial HYPER-H23-1 of DehydraTECH-CBD. This IND submission follows a successful pre-IND meeting with the FDA which provided Lexaria with guidance related to the development and filing of the IND. From 2018 through 2023, Lexaria sponsored five investigator-initiated human clinical studies of its DehydraTECH-CBD in an aggregate total of 134 people, without recording a single serious adverse event. These Studies evidenced significant reductions in resting blood pressure over both acute and multi-week dosing regimens alone and, in some cases, complementary to standard of care medications; suggesting that DehydraTECH-CBD has the potential to have broad therapeutic utility.
AREC

Hot Stocks

08:49 EST American Resources' ReElement enters MOU with Battery Damage Service - American Resource' ReElement Technologies has executed a MOU with Battery Damage Service GmbH. This MOU forms the collaborative framework to support a complete and EU-compliant, life-cycle solution for lithium-based batteries deployed throughout the EU marketplace, and marks the second recently announced agreement from ReElement to source recycled black mass from the German market. ReElement will refine the recycled battery material feedstock back to battery grade lithium products such as lithium carbonate and/or lithium hydroxide and nickel, manganese and cobalt sulfates at its Marion, Indiana and Noblesville, Indiana refining facilities to be reintroduced into the battery supply chain.
CEI

Hot Stocks

08:48 EST Camber Energy receives purchase order for VKIN-300 Waste Treatment system - Camber Energy announced that BOX 03 International issued a purchase order for a VKIN-300 Waste Treatment system designed by Camber's majority-owned subsidiary, Viking Ozone Technology. The VKIN-300 unit is intended for use by one of BOX 03's existing clients, a waste management company based in France that has been active in collecting, managing and treating waste from healthcare facilities for over twenty-five years.
AIP

Hot Stocks

08:47 EST Arteris selected by Rain AI for FlexNoC 5 NoC IP - Arteris announced that Rain AI has selected Arteris' FlexNoC 5 physically aware network-on-chip IP. The company will utilize the Arteris interconnect IP for its AI accelerator family. The on-chip connectivity enabled by Arteris' IP supports the design of an advanced mesh network topology for superior performance that helps support Rain AI's digital in-memory compute for AI workloads.
GM

Hot Stocks

08:46 EST GM developing new targets for Cruise, no timeline for relaunch
GM

Hot Stocks

08:46 EST General Motors to hold investor day 'later' this year, says CEO
SIGY

Hot Stocks

08:46 EST Sigyn Therapeutics announces 1-for-40 reverse stock split - Sigyn Therapeutics announced that a 1-for-40 reverse split of its common stock will be implemented tomorrow, January 31, 2024. As a result, the Company's common stock will trade on a post-split basis at the beginning of the trading day on January 31st under its existing trading symbol "SIGY." The CUSIP number for the common stock following the reverse stock split will be 82674U205. The reverse stock split is intended to increase the market price per share of the Company's common stock to gain compliance with the minimum bid listing requirement of The Nasdaq Capital Market in connection with the Company's pending application for listing. Proportionate adjustments will be made to the conversion and exercise prices of the company's warrants, restricted stock unit awards, stock options and to the number of shares issued and issuable under the Company's equity incentive plans.
UPS

Hot Stocks

08:45 EST UPS says volume ramped in Q4 - Says won back 60% of lost volume from union talks. Says workers expected to return to office 5 days per week in 2024. Plans to explore strategic options for Coyote unit.
MBTC

Hot Stocks

08:45 EST Nocturne Acquisition announces postponement of EGM - Nocturne Acquisition Corp. Board of Directors has voted in favor of postponing the meeting date for the Extraordinary General Meeting that was to be held on January 30, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. The Extraordinary General Meeting will now be held virtually on February 6, 2024 at 10:00 a.m. Eastern Time, and the Company plans to continue to solicit proxies from shareholders during the period prior to the Extraordinary General Meeting. The record date for the Extraordinary General Meeting remains the close of business on December 29, 2023. No changes have been made in the proposals to be voted on by the shareholders at the postponed meeting. Shareholders who have previously submitted their proxy or otherwise voted and who do not want to change their vote need not take any action. Stockholders as of the record date may vote, even if they have subsequently sold their shares. The deadline by which shareholders must exercise their redemption rights in connection with the Extraordinary General Meeting has been extended to two business days prior to the postponed meeting.
GM

Hot Stocks

08:45 EST General Motors to reduce costs by $2B in 2024, says CEO
UPS

Hot Stocks

08:44 EST UPS plans to cut 12,000 jobs, sees $1B cost reduction - Comments taken from Q4 earnings conference call.
WSTRF

Hot Stocks

08:44 EST Western Uranium & Vanadium appoints Michael Rutter as COO - Western Uranium & Vanadium announced the elevation of Michael Rutter to the position of Chief Operating Officer and the addition of Bruce Norquist to the team as General Manager of Mining Operations. Michael Rutter, who joined the company as Vice President of Operations in 2016, has been promoted to Chief Operating Officer. Bruce Norquist, P.E., has joined the Company as the General Manager of Mining Operations, overseeing resource extraction and development across various projects. At the Sunday Mine Complex, he is tasked with implementing the mine plan and refining development and production plans. At the San Rafael Project, Mr. Norquist will lead the advancement of permitting, production of the mine plan, and management of start-up and operations. He has had both on-site and corporate level engineering positions with Cotter Corporation and Energy Fuels Resources Corporation.
AMPG

Hot Stocks

08:42 EST AmpliTech Group's AmpliTech unveils new Ka Band LNB - AmpliTech announced its AmpliTech Inc Division's newest product release, a Ka Band LNB. Featuring its proprietary AmpliTech LNA low noise technology, this Ka Band LNB was designed for superior performance in small sats, LEO, MEO, GEO and portable or fixed Ka-Band teleport applications. This innovative new product is part of AmpliTech's rollout of targeted industry solutions that improve and transform current telecommunications technology. CEO Fawad Maqbool remarked, "LNBs are essential and located in the feed of the dish antennas that we see everywhere all over the world. The little box that is in the middle of the dish is an LNB that is responsible for picking up the small signals coming from streaming companies like Amazon, Disney, CNN, and a multitude of other entertainment providers. The higher performance in these LNBs, means less downtime and better quality of signal to your TV or laptop. So, the next time you get a nice clean picture on your TV, there is a hard-working LNB making this possible. AmpliTech is committed to making the highest performing LNBs in the industry for everyone's viewing pleasure."
BSGM

Hot Stocks

08:42 EST BioSig Technologies announces workforce reduction to decrease annual cash burn - BioSig Technologies announced a workforce reduction, intended to reduce annual cash burn by 50%. The Company is reducing its internal workforce, which is expected to be completed by January 31. The Company is also shifting its business model and seeks to partner with organizations for sales distribution and clinical support of its PURE EP Platform. Since its launch in Q4 2023, PURE EP's Near-Field Tracking has increased customer interest and usage at some of the country's largest and leading medical centers and health systems. This usage has also illustrated the need for increased clinical support as the Company seeks to install its PURE EP Platform in additional accounts. The Company is looking to partner with well-established electrophysiology companies and distributors that already have clinical staff in the hospital setting.
GURE

Hot Stocks

08:41 EST Gulf Resources announces completion of flood prevention project - Gulf Resources announced that it has completed its approximately $50M flood prevention project recently. This project was implemented for safeguarding its bromine facilities. While implemented to protect its bromine facilities and prevent potential flooding that could harm the wells, aqueducts and crude salt pans at the Company's plant, the Company expects two long-term benefits: 1. Cost Savings. Over the past six years, the Company has spent approximately $47 million repairing its facilities after two separate typhoons. This amount is close to the total cost of the flood prevention project. The Company believes the flood prevention project may mitigate the risks and associated expenses related to future storms-induced flooding and prevent major flooding in the future, ultimately saving money in the long run. 2. Enhanced Utilization. Through the flood prevention project, the Company believes it may be able to drill in certain low-lying areas that were previously not suitable for wells. This expansion may result in higher utilization rates, particularly as the markets for bromine and crude salt improve.
GILD

Hot Stocks

08:40 EST FDA approves manufacturing process change for Kite's Yescarta for TAT reduction - Kite, a Gilead Company announced that the U.S. Food and Drug Administration FDA has approved a manufacturing process change resulting in a shorter manufacturing time for Yescarta or axicabtagene ciloleucel. With this approval, Kite's median turnaround time TAT in the U.S. is anticipated to be reduced from 16 days to 14 days. "For patients with relapsed or refractory large B-cell lymphoma, every day matters as the patient's disease can be aggressive and worsen rapidly," said Cindy Perettie, Executive Vice President, Kite. "Yescarta is the first and only treatment to demonstrate superior overall survival over the standard of care as a second-line treatment with curative intent for these patients, and today's decision by the FDA allows us to further shorten our delivery time of Yescarta so that patients have the best possible chance of survival."..Kite has continued to increase its manufacturing network capacity to meet growing demand, ensuring scheduling availability
SHIP

Hot Stocks

08:40 EST Seanergy Marine achieves key partnership with E.U. funded SAFeCRAFT - Seanergy Maritime through its wholly-owned subsidiary Seanergy Shipmanagement, is the first Greek-based shipping company to accomplish a strategic partnership in the European Union, E.U., Funded SAFeCRAFT Project Consortium, a breakthrough initiative concerning the utilization of alternative fuels. Safecraft aims to demonstrate the safety and viability of Sustainable Alternative Fuels in seaborne transportation, accelerating the adoption of SAFs technologies. Seanergy will provide one of its existing, conventionally fueled Capesize vessels as the demonstrating vessel under Safecraft which will be retrofitted to utilize hydrogen as the main energy source for electric power generation. Stamatis Tsantanis, the Company's Chairman & Chief Executive Officer, stated: "We are the first Greek-based shipping company on this groundbreaking project. The strategic partnership with the European Union and key industry stakeholders is another major achievement of our Company towards our global ESG objectives. Safecraft is advancing our proven strategy of making the current vessels more efficient and potentially reducing radically GHG emissions by utilizing alternative fuels and new technologies on the existing fleet."
GM

Hot Stocks

08:40 EST General Motors sees selling at least 250,000 EVs this year, says CEO
EEIQ

Hot Stocks

08:39 EST EpicQuest Education reports current enrollment metrics - EpicQuest Education announced current enrollment metrics for its owned and operated schools, Davis University and EduGlobal College. In EduGlobal College, the company believes that it is performing very well in recruiting students during the academic year, with this effort expected to lead to a substantial increase in revenue. In the Fall 2023 semester, 13 students arrived at EduGlobal College and began their iUPP academic program. For the Spring term beginning in January 2024, the number increased by 192% year-over-year to a total of 38 students in the iUPP program, not including the 15 students whose visa applications are pending. In Davis University, there were 12 students enrolled in the foundational program of Davis University at Peking University for the Fall 2023 term beginning in September of 2023. For the Spring semester beginning in January of 2024, an additional 10 students were enrolled in the program, representing an 83% increase. There are now a total number of 60 students who are enrolled in the two foundational programs of Davis University. A total of 16 students entered the English Language Center at Miami University Regionals for the Spring 2024 term, representing a 46% year-over year increase as compared to the number of students registered in the Spring 2023 term.
GM

Hot Stocks

08:39 EST GM CEO: Pace of EV growth has slowed, which has created uncertainty
PLOW

Hot Stocks

08:38 EST Douglas Dynamics implements 2024 Cost Savings Program - The recently implemented 2024 Cost Savings Program, which is primarily in the form of salaried headcount reductions, impacted both the Work Truck Attachments segment and corporate functions. The structural changes are anticipated to yield annual pre-tax savings of $8 million to $10 million, with approximately 75% of the anticipated annualized savings expected to be realized in 2024. The implementation of these initiatives is expected to lead to approximately $2 million in pre-tax restructuring charges related to workforce reduction costs and other related expenses. We expect to incur these charges primarily in the first quarter of 2024, and Adjusted EBITDA will be adjusted for any items affecting comparability. McCormick explained, "While our business model is designed to adapt quickly to temporary weather driven challenges, the historic low snowfall trends seen in the past few years has led us to look beyond our typical cost cutting measures. While we expect to unlock significant savings from the initiatives, we remain equally confident in protecting and growing our competitive advantages, which leaves us well positioned to drive growth over the medium- to long-term."
RELI

Hot Stocks

08:38 EST Reliance Global's RELI Exchange launches client referral portal - Reliance Global Group announced that it has added the RELI Exchange Client Referral Portal, CRP, into its proprietary InsurTech platform, RELI Exchange. Ezra Beyman, CEO of Reliance, stated, "Since its inception, RELI Exchange has been consistently evolving to offer better functionality and provide greater benefits to our existing and prospective agency partners. We recently launched the proprietary RELI Exchange CRP, designed to help agency partners establish and strengthen connections with a range of professional service providers, including but not limited to, real estate agents, car dealerships, and mortgage brokers. These professionals frequently interact with clients in need of insurance products. Using this new feature, agency partners can easily generate a unique affiliate link for each referral partner, making the process straightforward for the referral partner's clients to access and purchase insurance services from a specific RELI Exchange agency partner."
PLOW

Hot Stocks

08:37 EST Douglas Dynamics says Solutions segment completed strong finish to 2023 - The Solutions segment completed a strong finish to 2023, producing double digit EBITDA margins in the fourth quarter of 2023. On a full year basis, initial results indicate Net Sales growth above 15% and adjusted EBITDA growth of approximately 100% when compared to 2022 results, which is a testament to the progress made on margin improvement and baseline profit initiatives. "I'm pleased to say that Solutions delivered year over year margin improvement each quarter this year, as planned. We enter 2024 with optimism based on our strong fourth quarter performance, ongoing positive demand and continued elevated backlog," noted McCormick.
INBS

Hot Stocks

08:37 EST Intelligent Bio Solutions announces benefits of fingerprint drug system - Intelligent Bio Solutions reported on the key operational benefits that customers are experiencing following deployment of the Intelligent Fingerprinting Drug Screening System to support workplace drug testing. Customers across critical sectors such as construction, manufacturing and logistics are reporting substantial advantages post-implementation of the system, including: enhanced control over drug screening processes by transitioning to in-house; improvements in workplace productivity; streamlined project compliance; and significant cost savings. "We're seeing an increasing need for drug and alcohol testing across major construction and manufacturing projects. Modern HSEQ and HR teams are recognizing that conventional drug testing approaches simply are not meeting the growing demands for improved operational efficiencies," explained Harry Simeonidis, President and Chief Executive Officer at Intelligent Bio Solutions. "This realization is driving rapid customer adoption of our Intelligent Fingerprinting Drug Screening System, which not only offers a non-invasive, quick and easy solution but also improves efficiencies and unlocks significant productivity savings."
KMB

Hot Stocks

08:37 EST Kimberly-Clark appoints Grant McGee as Senior VP and General Counsel - Kimberly-Clark appointed Grant McGee to Senior VP and General Counsel, effective Feb. 1. He will report to Jeff Melucci, who is expanding his enterprise responsibilities as Chief Business and Transformation Officer. McGee will also become a member of Kimberly-Clark's executive leadership team. McGee rejoins Kimberly-Clark from American Airlines, where he served as vice president, deputy general counsel and corporate secretary. Before that, he served in various roles of increasing responsibility at Kimberly-Clark from 2015 to 2022.
PLOW

Hot Stocks

08:37 EST Douglas Dynamics says lack of snowfall significantly impacted Q4 results - The Attachments segment continues to navigate the highly unusual weather trends which began in the fourth quarter of 2022 and continued through the fourth quarter of 2023. Following record low snowfall on the east coast during the 2022-23 snow season, demand was already negatively impacted entering the fourth quarter 2023 equipment retail season. The situation was compounded by fourth quarter 2023 snowfall totals that were nearly 70% below the ten-year average, resulting in the lowest fourth quarter order activity on record, which was more than 60% below the ten-year average. For 2023, initial results indicate Attachments Net Sales will be more than 20% lower than the previous year, with adjusted EBITDA approximately one-third lower than 2022 results. "The lack of snowfall was the reason our 2023 results came in well below our expectations," explained Bob McCormick, President and CEO. "Douglas has been in the weather business for over 75 years, and we've seen our share of low snowfall environments, but the past 15 months have been one for the record books. Until earlier this month, there was a record approximate 700-day gap between measurable snowfalls in important east coast markets such as New York, Philadelphia, Baltimore, and Washington D.C." McCormick continued, "More than two-thirds of a season's snowfall typically occurs in the first quarter and I'm glad to say snowfall in the first quarter of 2024 is off to a positive start. We've seen a succession of storms across the snowbelt in January, including in core east coast markets." "Due to the unprecedented nature of the weather patterns we've experienced, the equipment replacement cycle has lengthened, likely taking us more than one snow season to return to an average demand environment. Therefore, we made the prudent decision to align our cost structure and effectively manage through this highly unusual period."
GM

Hot Stocks

08:36 EST GM plans to reduce shares outstanding to fewer than 1B, says CEO - Comments taken from Q4 earnings conference call.
SIBN

Hot Stocks

08:35 EST SI-Bone receives FDA 510k clearance for smaller diameter of iFuse Implant - SI-BONE announces FDA 510(k) premarket clearance of the iFuse Bedrock Granite Implant System in a smaller diameter with both an expanded indication in pediatric patients and an expanded application that includes use in the S1 trajectory. When placed across the SI joint, the Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for multi-segment spinal fusion. This 510(k) clearance follows the initial clearance of the iFuse Bedrock Granite System in May 2022 that included implants of 10.5 mm and 11.5 mm in diameter.
IINN

Hot Stocks

08:35 EST Inspira Technologies signs distribution agreement to enter Gulf States - Inspira Technologies announced its summary distribution agreement with Glo-Med Networks, a U.S. company with a regional office in Jeddah, Saudi Arabia. Under the Agreement, Glo-Med will be designated as the company's distributor in Saudi Arabia, United Arab Emirates and Bahrain. Inspira stated that it believes that Saudi Arabia's dual strategy to invest $65B and further privatize its healthcare sector, or Vision 2030, signals that the Territory is a burgeoning market for medical innovation. The summary distribution agreement will be followed by a more comprehensive agreement. Glo-Med will be the exclusive Territory distributor of the Devices provided that it meets the minimum purchase targets amounting to 531 INSPIRA ART devices and 8,794 disposable units from when the relevant regulatory approvals for the Devices in the Territory are granted.
OSS

Hot Stocks

08:34 EST One Stop Systems brings AI edge compute solutions to motorsport industry - One Stop Systems has shipped to legendary motorsport champion, Andretti Global, its first AI Transportable compute system for the motorsport industry. An OSS SDS-3U GPU-accelerated server will power advanced AI race analytics for Andretti using Zapata AI's Industrial Generative AI platform for the cloud and edge, Orquestra. The solution represents a new application of OSS technology and the company's first foray into the $5.1 billion motorsport industry. "This milestone win demonstrates our unique capabilities for powering generative AI technology at the edge," noted OSS CEO, Mike Knowles. "We see this new application of our technology leading to other significant opportunities within the fast-growing motorsport space, as well as other domain-specific industrial-scale applications."
CRMD

Hot Stocks

08:33 EST CorMedix announces commercial, reimbursement updates - CorMedix announced updates related to its business and anticipated launch of DefenCath. Recent Updates: On January 25, 2024 the Center for Medicare & Medicaid Services notified CorMedix that the agency has determined DefenCath will be eligible for reimbursement in accordance with the ESRD PPS. As such, CorMedix is entitled to submit an application for a Transitional Drug Add-On Payment which currently allows for five years of additional payment reimbursement to outpatient providers. As a result of CMS' determination that DefenCath is within the scope of the ESRD PPS and eligible for TDAPA, CorMedix has established its list price of $249.99 per 3ml vial, to account for the market dynamics and functionality of the TDAPA framework. CorMedix previously applied for and received a New Technology Add-On Payment from CMS for inpatient reimbursement of DefenCath. CorMedix reiterates its previously disclosed launch guidance of April 15, 2024 for inpatient commercialization, and a target of July 1, 2024 for the commencement of outpatient commercialization.
CPS NKE

Hot Stocks

08:33 EST Nike extends licensing agreement for Cooper-Standard's footwear material - Cooper Standard (CPS) announced its partnership with Nike (NKE), including a new expansion of its technology licensing agreement. Based on the initial long-term agreement reached in 2021 to license Cooper Standard's Fortrex material platform for footwear applications, the new agreement provides Nike with limited exclusivity to use the Fortrex material for footwear and allows them to develop new applications for use in additional product lines. The Fortrex material platform is Cooper Standard's proprietary elastomeric material that can be used in a wide range of applications including automotive sealing systems, shoe midsoles, and potentially many others.
MOBX

Hot Stocks

08:30 EST Mobix Labs begins filtered connector parts deliveries used in Tomahawk missiles - Mobix Labs (MOBX) announced it has begun delivering filtered connector parts that are used in the U.S. Navy's Tomahawk Cruise Missile. Financial details were not disclosed. According to a recent article in Newsweek, the U.S. has thousands of Tomahawk missiles in its arsenal and in vessels deployed around the world. The Tomahawk cruise missile is a long-range precision weapon launched from the U.S. military's ships and submarines. It can "strike targets precisely from 1,000 miles away, even in heavily defended airspace," according to the missile's manufacturer, defense giant Raytheon. The Company is excited to announce another defense industry program using its components as a result of its M&A growth strategy. The Company will continue to engage in additional accretive M&A activities that will increase its access to additional marketplaces and industry verticals.
ZTEK

Hot Stocks

08:29 EST Zentek's Triera completes testing of C19HBA aptamer as potential therapeutic - Zentek subsidiary Triera Biosciences has completed testing of its C19HBA aptamer as a potential therapeutic. The SARS-CoV-2 universal aptamer built on the proprietary high-binding affinity aptamer platform successfully outperformed a leading monoclonal antibody in preclinical testing demonstrating potential as a therapeutic for SARS-CoV-2. The Company previously reported successful results when C19HBA was tested as a prophylactic treatment. In repeated prophylaxis trials against SARS-CoV-2 variants, including Omicron XBB 1.5 variant, C19HBA has matched or exceeded the clinical protection when compared to LMA. In the most recent trial completed in January 2024 by the Miller lab at McMaster University, C19HBA was tested for its therapeutic potential. Mice were first infected with a lethal challenge of ancestral SARS-CoV-2 and 24 hours later, the mice received either no treatment, LMA treatment, or a treatment featuring C19HBA. LMA treatment demonstrated some clinical benefit compared to the untreated mice, however, weight loss curves and recovery time were not materially improved between LMA-treated and untreated groups. In contrast, the treatment that featured C19HBA demonstrated improved therapeutic benefit over either no treatment or the LMA therapeutic as evidenced by: Initial signs of recovery and full recovery of the C19HBA-treated mice occurring one day earlier than LMA treated or untreated mice; and A 30% reduction in total average weight loss of C19HBA treated mice compared to the average weight loss of untreated and LMA-treated mice. The full results of this preclinical investigation are pending publication in a peer reviewed journal.
VYEY

Hot Stocks

08:27 EST VIctory Energy announces collaboration with Redding Rancheria EDC - Victory Clean Energy subsidiary H2 Energy Group and Redding Rancheria Economic Development Corporation are pleased to announce their new venture in Northern California. Through this project, H2 Energy Group will work with Redding Rancheria Economic Development Corporation to bring Affordable TrueGreen Hydrogen to Native American communities and Disadvantaged Communities in the area. H2 Energy Group will provide completely Sustainable TrueGreen Hydrogen technology and expertise to help these communities transition to Sustainable energy sources and reduce their reliance on fossil fuels.
SOBR

Hot Stocks

08:25 EST SOBR Safe launches alcohol detection wearable in Australia, New Zealand - SOBR Safe has initiated SOBRsure sales activities in Australia and New Zealand - via an international channel partnership with Drug Testing Business Success, the region's leading drug and alcohol testing service provider. Drug Testing Business Success has deep experience in the transdermal alcohol detection industry, having represented the world's most widely-used ankle bracelet for 14 years. Drug Testing Business Success intends to drive SOBRsure orders through a coalition of suppliers and a dedicated e-commerce website, with a focus on behavioral health and justice. Following a 90-day proof-of-concept, SOBRsure has been launched for sale and is in active client use.
BHC

Hot Stocks

08:24 EST Bausch Health announces CABTREO topical gel availability in the U.S. - Bausch Health Companies announced the U.S. launch of CABTREO Topical Gel, 1.2%/0.15%/3.1% indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. CABTREO Topical Gel is the first and only U.S. Food and Drug Administration-approved fixed-dose, once-daily triple-combination topical treatment for acne and offers three mechanisms of action, combining an antibiotic, retinoid and antibacterial, to provide a proven, safe and effective treatment.
DSS

Hot Stocks

08:21 EST Imapct Biomedical announcse U.S. patent allowance of Laetose technology - Impact Biomedical, in which DSS has a significant investment, announces a milestone in its Laetose technology platform. The U.S. Patent and Trademark Office, USPTO, has issued U.S. patent # 11,898,184, entitled "Low Glycemic Sugar Composition" developed within this platform. The Laetose technology demonstrates compelling potential in reducing caloric intake and glycemic index in foods, while also inhibiting tumor necrosis factor alpha, a cytokine associated with inflammatory chronic diseases. The patented formulation is a novel combination of one or more sugars and myo-inositol, with potential to inhibit the inflammatory and metabolic response of sugar alone. This marks the first Laetose patent issued in the U.S., emphasizing IBIO's commitment to discovering, developing, and patenting unique technologies to address unmet needs in human healthcare. The term of this US patent will expire in 2037. Potential Applications and Market Impact: US Inflammatory Disease Treatment Market: Estimated at $35B; US Diabetes Treatment Market: Currently at $30B and projected to grow to $61B by 2028; US Refined Sugar Production Market: Valued at $12B and expected to grow to $26B by 2028. Impact Biomedical CEO Frank D. Heuszel commented, "This is another demonstration of our commitment to address critical unmet needs in human healthcare. We are accelerating discussions with potential licensing and development partners to move Laetose rapidly towards the market in the US and other countries worldwide."
BTGOF RKNEF

Hot Stocks

08:21 EST BT Group selects Optiva to develop B2B, B2C, B2B2X services - BT Group has extended its strategic partnership with Optiva to develop and monetize new B2B, B2C and B2B2X services. Optiva's application server, a key component of the Optiva Charging Engine, will be upgraded to a next-generation, cloud-native, open architecture service creation platform. It will include Optiva's Open API framework, enabling integration with new cutting-edge technology partners, including blockchain and artificial intelligence tools, fostering the growth of new services and new revenue opportunities.
MTEK

Hot Stocks

08:19 EST Maris-Tech announces backlog of approximately $10,800,000 - Maris-Tech announced that the Company's backlog as of January 29, 2024, reached a record high of approximately $10,800,000. The Company defines backlog as the accumulation of all pending orders with a later fulfillment date for which revenue has not been recognized and the Company considers valid. The backlog consists of executed purchase orders from new customers and existing customers with which we have had long-standing relationships and from governmental agencies. "We are very pleased with the successes of 2023, gaining new and repeat business that is also reflected in a record backlog of orders. The backlog reflects the continued demand for our innovative defense and AI-powered solutions, which has increased the Company's backlog consistently. We eagerly anticipate meeting the challenges, expectations and goals of 2024," said Israel Bar, CEO of Maris-Tech.
IDEX

Hot Stocks

08:19 EST Energica Inside enters agreement with Nimbus for electric powertrain - Energica Inside has signed an agreement to provide technology to help electrify the historic Nimbus Model C motorcycle. As part of the agreement Energica Inside will support Nimbus's release of the classic Model C as an electric motorcycle.
INKT

Hot Stocks

08:18 EST MiNK Therapeutics announces publication of case report on agenT-797 - MiNK Therapeutics announced the publication of a case report in Oncogene from its phase 1/2 study in patients with advanced solid tumors where one infusion of agenT-797 in gastric cancer refractory to anti-PD1 led to a durable confirmed partial response, highlighting the unique potential of iNKT cells to overcome resistance to immune checkpoint inhibitors, ICIs. "Gastric cancer remains an area of high unmet need, where the majority of patients develop disease progression related to tumor resistance," said Dr. Benedito Carneiro, Director of Clinical Research, Director of Cancer Drug Development, Associate Director of the Division of Hematology/Oncology, Legorreta Cancer Center at Brown University. "Novel therapeutic approaches, like allogeneic iNKT cells, are urgently needed to overcome resistance to immune checkpoint inhibitors in gastric cancers and other refractory solid tumors. The activity, tolerability, and ease of off-the-shelf administration of iNKT-based cell therapies position them as an attractive approach for overcoming cancer resistance." This case report describes a durable response in a patient with a challenging clinical profile-a PD-L1 positive, HER-2 negative, MSI-H adenocarcinoma with a high mutational burden. Prior treatments, including single-agent anti-PD-1 pembrolizumab, had failed to elicit a response, prompting a combination therapy approach involving chemotherapy and nivolumab. However, even this combined regimen proved ineffective before the patient's enrollment in MiNK's clinical trial. Following treatment with agenT-797, increased immune cell infiltration and proliferation were observed, which correlated with the radiographic partial response.
IDN

Hot Stocks

08:18 EST Intellicheck completes 3rd-party surveillance audits to retain certification - Intellicheck announced it has successfully completed intensive third-party surveillance audits to retain certification status for another year from the International Standards Organization for ISO/IEC 27001:2013 and ISO/IEC 27701:2019 certification. Intellicheck CEO Bryan Lewis said the recertifications underscore the company's dedication to the most rigorous standards for securing both customers' and company data. "This achievement is one more validation of the strength of our commitment to our clients, partners, and stakeholders. Intellicheck remains a world-class company at the forefront in providing market leading on-demand digital and physical validation solutions that accelerate customer onboarding and enhance trust with a secure, frictionless experience while assuring the utmost standards in data security and privacy."
TRU T

Hot Stocks

08:17 EST TransUnion, AT&T launch in-network branded call display with logos - AT&T (T) and TransUnion (TRU) are now offering outgoing calls for businesses that display a brand name and logo on the receiver's phone - with two new features to improve consumer trust: Recipients no longer need a special app on their mobile device to see the caller's brand logo. The branded calls with logos are verified with STIR/SHAKEN, a set of standards used to help confirm the number has not been illegally spoofed. "The delivery of Branded Call Display logos represents the culmination of years of collaboration between AT&T and Neustar, now part of TransUnion," said James Garvert, TransUnion senior vice president and general manager, TruContact Communications Solutions. "We have delivered Caller ID for landlines, evolved to the first generation of branded calling, and now we've set the stage for Branded Calls Display logos. This is helping restore trust in the phone to protect enterprises and consumers alike."
CACI

Hot Stocks

08:17 EST CACI announces five-year, single-award task order of up to $81M - CACI announced that it won a five-year, single-award task order valued at up to $81M to provide expertise to the Defense Intelligence Agency, or DIA, National Media Exploitation Center, or NMEC. The Storefront and Dissemination Support task order will provide global information technology operational, sustainment, and modernization for databases across the intelligence community and the Department of Defense.
FVRR

Hot Stocks

08:17 EST Fiverr announces Winter Product Release - Fiverr announces its Winter Product Release, the first of two major releases in 2024. This is more than just an update; it's an innovative response to the feedback from the freelancers and businesses Fiverr has served over the last 14 years. New features include a Consulting Category of top-tier industry experts, the introduction of Fiverr Agencies, designed to meet the unique needs of agency teams, and an actionable rating and review system, among others. Fiverr continues to mold its platform to empower its community and further its position as a trusted partner for any digital service.
ANVS

Hot Stocks

08:15 EST Annovis Bio announces filing of new patent application for mental illnesses - Annovis Bio announced the filing of a patent application covering the use of buntanetap and its analogues for the treatment of neuropsychiatric indications. This application follows the U.S. Provisional Application No. 63/440,890 which was filed on January 24, 2023. The patent application titled "Treatment of Mental Illness via Administration of Buntanetap and Analogues Thereof" addresses methods for treating, inhibiting, reducing, slowing, or delaying onset of mental illnesses by administration of buntanetap or its pharmaceutically acceptable salts. Buntanetap can be used alone or synergistically with effective quantities of antipsychotic agents, antidepressant agents, hallucinogenic agents, or combinations thereof. "The ability of buntanetap to inhibit a wide range of neurotoxic proteins, as shown in our Alzheimer's and Parkinson's studies, is associated with improved mental health which opens new avenues for delaying or treating certain mental conditions," said Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis. "The filing of this patent application serves as a robust reinforcement of our intellectual property portfolio, bolstering our mission to bring therapeutic solutions for brain-related disorders to market, which now also include mental illness in addition to neurodegeneration diseases."
PRPH

Hot Stocks

08:15 EST ProPhase Labs announces Karkus became President of Nebula Genomics - ProPhase Labs reported that Jason Karkus became President of Nebula Genomics, a wholly-owned subsidiary of ProPhase Labs. In his new role, Karkus aims to amplify the Nebula Genomics business-to-business operations, as well as its exciting direct-to-consumer Whole Genome Sequencing model. This strategic move is in line with ProPhase's evolution from a high complexity molecular Covid testing laboratory to an advanced WGS pioneer.
BNGO

Hot Stocks

08:14 EST Bionano Genomics announces conclusion of 2024 Symposium - Bionano Genomics announced the conclusion of Bionano's 2024 Symposium, the quintessential event for the optical genome mapping community, which was held January 22-25, 2024, and featured a record 32 oral presentations and 69 scientific posters from genomic scientists at leading institutions, including Brigham and Women's Hospital, The University of Texas MD Anderson Cancer Center, Institute Curie, Memorial Sloan Kettering Cancer Center and Johns Hopkins University School of Medicine. Symposium had over 2,100 registrants from 92 countries and averaged 574 attendees per day. During this four-day online event, presenters reported on their use of OGM for applications in cancer, genetic disease, and cell and gene therapy.
MFG

Hot Stocks

08:13 EST Mizuho Financial Group's Mizuho Americas invests in DirectBooks - Mizuho Americas announced its strategic investment in DirectBooks, the leading primary markets communications platform. Through this investment, Mizuho will join the board of directors and work directly with other top-tier investment banks to enhance capital markets globally. "DirectBooks has emerged as an important provider of innovative solutions for the capital markets," said Jerry Rizzieri, President and CEO, Mizuho Securities USA. "We look forward to playing a larger role in their continued success."
ICAD

Hot Stocks

08:13 EST iCAD appoints Michael Doyle to board of directors - iCAD announced the appointment of Michael J. Doyle to its Board of Directors, effective immediately. He is currently the CEO of Spire Health.
APH CIT

Hot Stocks

08:12 EST Amphenol acquisition of Carlisle's CIT Group for $2.025B seento be accretive - Amphenol Corporation (APH) announced a definitive agreement to acquire the Carlisle Interconnect Technologies or CIT, business of Carlisle Companies Incorporated (CSL) for $2.025B in cash..."CIT is a leading global supplier of harsh environment interconnect solutions primarily to the commercial air, defense and industrial end markets, and is expected to have 2024 sales and adjusted EBITDA margin of approximately $900M and 20%, respectively. " Assuming a continuation of current economic conditions, CIT is expected to be accretive to Amphenol's earnings per share in the first year post closing, excluding acquisition-related costs. The acquisition of CIT will be financed through a combination of cash on hand as well as the Company's existing credit and commercial paper facilities. The transaction is expected to be completed by the end of the second quarter of 2024 and is subject to certain regulatory approvals and other customary closing conditions.
AQMS

Hot Stocks

08:12 EST Aqua Metals secures tax abatement for Sierra ARC battery recycling campus - Aqua Metals announced the receipt of an economic incentive package of approximately $2.2 million from the Nevada Governor's Office of Economic Development, GOED, which will assist the Company in its Nevada expansion. Pursuant to the terms of the abatement, this impactful support encompasses partial tax relief over a ten-year period towards approximately $17 million worth of equipment and $18 million worth of building and land improvements planned for the first phase of the Company's Sierra AquaRefining Campus, ARC. "We are immensely grateful for the programs from the State of Nevada via the Governor's Office of Economic Development that support new and expanding companies and appreciate the strong affirmation of our innovative approach to sustainable recycling," said Steve Cotton, President and Chief Executive Officer of Aqua Metals. "This economic incentive will bolster our efforts at the Sierra ARC, further enabling us to continue creating good-paying jobs and contribute even more significantly to Nevada's growing clean energy sector."
NHWK

Hot Stocks

08:11 EST Scorpius Holdings receives proceeds of $3.25M in sale of non-core IP - NightHawk Biosciences has sold additional none-core IP. Additionally, the Company received proceeds of $2.25 million from a note issued pursuant to the terms of the previously announced divestiture of non-core assets. The Note bears interest at an annual rate of 1% and, subject to stockholder approval, would be convertible into shares of NightHawk's common stock at $0.39281 per share, an 8% premium to the closing price of the Company's common stock on January 29, 2024. Additional details related to the sale of the IP and the Note are included in the Company's Form 8-K, which has been filed with the Securities and Exchange Commission.
A INCY

Hot Stocks

08:11 EST Agilent, Incyte collaborate to develop advanced companion diagnostics - Agilent (A) announced an agreement with Incyte (INCY) that will bring together Agilent's expertise in the development of companion diagnostics, or CDx, to support the development and commercialization of Incyte's hematology and oncology portfolio. The agreement between Agilent and Incyte allows the companies to collaborate on CDx development programs. This will enable Agilent to continue to expand its companion diagnostics portfolio with novel biomarkers and Incyte to leverage Agilent's expertise in IVD assay development, global regulatory approvals, and commercialization to support clinical trials as well as the potential registration and commercialization of CDx in the United States and Europe.
WKSP

Hot Stocks

08:10 EST Worksport subsidiary Terravis Energy starts to build heat pump supply chain - Worksport announces that Terravis has begun to consider partners in a supply chain for the Cold Climate, Air Source Residential Heat Pump, CCHP. Terravis CEO Lorenzo Rossi recently returned from Chicago's 2024 AHR Expo, which attracted more than 50,000 attendees and more than 1,600 exhibits. Lorenzo Rossi attended the AHR Expo with a strategic objective - meeting suppliers and instituting a commercial supply chain for the revolutionary CCHP. "We have reached a tipping point in the development of the Terravis Heat Pump, as it has gone through some ultra-demanding tests in our Toronto R&D facility's cutting-edge 'Arctic Chamber' and is now undergoing extra tests. It was a great experience to be at the AHR Expo alongside leading companies like Bosch Ltd, Honeywell International, Hitachi Heating and Cooling, and LG Electronics." Lorenzo Rossi continued. "The next step is finding the best suppliers who share our vision for this technologically advanced, zero emission product. We are very encouraged by high level of technology of the suppliers at the Expo. They came from all over the world, and Terravis Energy forged vital industry connections and discovered how these potential partners can help move forward the development of this very promising product."
MOTS

Hot Stocks

08:09 EST Motus GI Holdings publishes results from European study of Pure-Vu system - Motus GI Holdings announced the publication of positive data from a study of the second generation Pure-Vu System in a manuscript titled, "An intraprocedural bowel cleansing system for difficult-to-prepare patients-A multicenter prospective feasibility study," in the peer-reviewed journal, United European Gastroenterology. The Company's Pure-Vu System is an FDA-approved and CE-certified bowel cleansing system intended to increase visualization in inadequately prepared colons by offering intraprocedural cleansing. The single arm, international, multicenter colonoscopy study evaluated if an adequate level of bowel cleansing could be achieved with the Pure-Vu System in patients with previous poor bowel preparation. The study enrolled a total of 44 patients with previous poor bowel preparation within the last 2 years. Typically patients with a history of poor bowel prep are prescribed a more aggressive prep regime on their follow up colonoscopy, whereas in this study all patients received a limited bowel preparation followed by intra-procedural bowel cleansing with the Pure-Vu System. The BBPS was assessed before and after segmental washing by the endoscopist who performed the procedure and later by an independent endoscopist. The study exclusion criteria included previous colon resection, previous colorectal cancer, colitis, lower gastrointestinal bleeding with hemodynamic instability, ASAgreater than3, insufficiently corrected anticoagulation disorders, inability to provide informed consent. Results from the study met the primary endpoint, showing a median BBPS increase from 1-2-2 to 3-3-3 with 31.8% and 88.6% of patients adequately prepared before and after using the Pure-Vu System, respectively. The study also met its key secondary endpoints. The study reported a cecal intubation rate was 88.6%, and, in patients with complete colonoscopy, the adequate cleansing rate was 97.5%. Median total procedure time was 26 minutes, of which 5.3 minutes were spent on cleaning. General ease of use was scored with a median of 4 out of 5, representing "as good as conventional colonoscopy." No serious adverse events occurred.
CTNT

Hot Stocks

08:09 EST Cheetah Net Supply Chain Service to acquire Edward Transit Express Group - Cheetah Net Supply Chain Service announced that it has executed a definitive agreement and its amendment thereto for the acquisition of Edward Transit Express Group, a California-based global inbound non-vessel operating common carrier specializing in ocean and air transportation services. This strategic move marks Cheetah's inaugural investment in the logistics sector. The Acquisition is expected to close within 20 calendar days from the signing of the Agreement. Chairman and CEO Tony Liu commented, "we look forward to closing the Acquisition and to integrating Edward's operations into Cheetah as soon as possible. We expect Edward's logistics and warehousing services to reduce Cheetah's operating overhead and, more importantly, to jumpstart Cheetah's ability to offer these services to third-party parallel-import dealers." The total Acquisition cost includes a cash payment of $300,000 and a share consideration involving the issuance of Cheetah's unregistered Class A common stock. The per-share price for the Share Consideration will be determined at 80% of the average closing price over the last ten business days preceding the execution of the Agreement, resulting in a market value of $1,200,000. Following the Acquisition, Cheetah will own 100% of Edward.
ACBA

Hot Stocks

08:09 EST Ace Global Business Acquisition extends period for initial business combination - Ace Global Business Acquisition announced that Ace Global Investment Limited, the company's initial public offering sponsor, has deposited into the company's trust account an aggregate of $98,858.95 representing, approximately $0.05 per ordinary share, in order to extend the period of time the company has to complete a business combination for an additional one month period, from February 9 to March 8. The company issued a promissory note to the Sponsor with a principal amount equal to the amount deposited. The promissory note bears no interest and is convertible into the company's units at a price of $10.00 per unit at the closing of a business combination by the Company. The purpose of the extension is to provide time for the company to complete a business combination.
MXCT

Hot Stocks

08:07 EST MaxCyte, Wugen announced the signing of a strategic platform license - MaxCyte and Wugen announced the signing of a strategic platform license, SPL. Under the terms of the agreement, Wugen gains non-exclusive clinical and commercial rights to use MaxCyte's Flow Electroporation technology and ExPERT platform. In return, MaxCyte will receive annual license fees and program-related revenue. Wugen is developing the next generation of off-the-shelf memory natural killer and CAR-T cell therapies for cancer. The company's investigational cell therapies originate from healthy donors and are further engineered to enhance their function of eliminating cancer cells. "As WU-CART-007 is transferred onto the ExPERT platform and continues to progress in the clinic, we are able to support efficient and seamless expansion to large-scale manufacturing," said Maher Masoud, President and CEO of MaxCyte. "By working with MaxCyte, Wugen can maximize the number of doses in each manufacturing run for later stage clinical development and potential commercial phase."
AVRO TECX

Hot Stocks

08:07 EST Avrobio, Tectonic Therapeutic to combine in an all-stock transaction - Avrobio (AVRO) and Tectonic Therapeutic announced that the companies have entered into a definitive merger agreement to combine in an all-stock transaction. Under the terms of the agreement, Avrobio will acquire 100% of the outstanding equity interests of Tectonic. Upon completion of the merger, the combined company is expected to operate under the name Tectonic Therapeutic and trade on Nasdaq under the ticker symbol (TECX). In connection with the merger, Tectonic has raised or entered into agreements for a $130.7M private placement with a syndicate of new and existing leading life sciences investors, led by a major mutual fund, TAS Partners, 5AM Ventures, EcoR1 Capital, Polaris Partners, funds and accounts advised by Farallon Capital Management, Vida Ventures, PagsGroup, and other investors. The combined company is expected to have approximately $165M of cash and cash equivalents at closing, inclusive of the proceeds to be received in the private placement. These proceeds will be used to advance Tectonic's pipeline through multiple clinical data catalysts and are expected to fund the combined company's operations into mid-2027. The private placement is expected to close in conjunction with the merger in the second quarter of 2024. Upon completion of the Merger, pre-Merger AVROBIO shareholders are expected to own approximately 22.3% of the combined company and pre-Merger Tectonic shareholders are expected to own approximately 40.2% of the combined company, and in each case after giving effect to the aforementioned private placement financing. The percentage of the combined company that Avrobio shareholders will own as of the close of the transaction is subject to adjustment based on the amount of Avrobio net cash at the closing date, which is currently estimated to be approximately $65M. Immediately prior to the closing of the Merger, Avrobio shareholders will be issued contingent value rights representing the right to receive certain payments from proceeds received by the combined company, if any, related to certain pre-transaction assets of Avrobio. Following the closing of the merger, the combined company will be led by Dr. Reicin and other members of the Tectonic management team. Avrobio will be renamed Tectonic Therapeutic and the corporate headquarters will be located in Watertown, Massachusetts. The merger agreement provides that post-merger, one board member from Avrobio will join the board of directors of the combined company. The merger has been approved by the board of directors of both companies and is expected to close in the second quarter of 2024 subject to customary closing conditions, including the approvals by the shareholders of each company, the closing of the private placement financing and other customary closing conditions. In connection with the Merger, directors, officers, and certain shareholders of Avrobio and Tectonic have executed support agreements, pursuant to which they have agreed to vote all of their shares of capital stock in favor of the merger.
OSA

Hot Stocks

08:07 EST ProSomnus announces FDA acceptance of 510(k) submission for EVO device - ProSomnus announced that the United States Food and Drug Administration has accepted, and is in the process of reviewing, the Company's premarket notification for its ProSomnus EVO precision medical device for the treatment of patients with severe obstructive sleep apnea. The Company's premarket notification 510(k) submission included a robust clinical data dossier demonstrating the safety and efficacy of its ProSomnus EVO precision medical device relative to the performance goals indicated in pre-submission meetings and reference devices. The clinical data submitted by the Company in support of its 510(k) submission included data on 92 patients with severe OSA from two prospective clinical studies.
PRKS SEAS

Hot Stocks

08:07 EST SeaWorld to change name to 'United Parks & Resorts' on February 12 - SeaWorld Entertainment announced it will change its name to United Parks & Resorts, effective Feb. 12. The company's stock ticker symbol on the New York Stock Exchange will change from "SEAS" to "PRKS," with trading as PRKS to begin Feb. 13. The name change affects only the name of the parent company, SeaWorld Entertainment, the company noted.
ICCM

Hot Stocks

08:07 EST IceCure Medical's appeal for ProSense in breast cancer accepted by FDA - IceCure Medical announced the FDA has responded affirmatively to the company's request for supervisory review regarding the FDA's prior denial of IceCure's De Novo Classification Request for treating patients with early-stage, low risk breast cancer. The FDA determined there is sufficient basis to reopen the De Novo file and requested IceCure to submit the full 5-year dataset from the company's ICE3 trial. The final ICE3 study patient is expected to complete her 5-year follow up examination by the end of February 2024. IceCure plans to expedite data monitoring and analysis to submit the final 5-year dataset to the FDA by April 2024, which is several months ahead of the company's prior submission timeline. Additionally, the FDA requested that IceCure submit an analysis of the ICE3 results compared with data from the LUMINA study. IceCure was invited by the FDA to submit real-world data from the use of ProSense globally, including post-market commercial use in territories where ProSense is approved for breast cancer, as well as data from independent third-party studies.
CSL APH

Hot Stocks

08:06 EST Carlisle to sell CIT unit to Amphenol in transaction valued at $2.025B - Carlisle Companies Incorporated (CSL) announced the signing of a definitive agreement to sell Carlisle Interconnect Technologies or CIT to Amphenol Corporation (APH) in a transaction valued at $2.025 B. The transaction, which follows Carlisle's previously announced process to sell CIT, is subject to certain closing adjustments and conditions, including regulatory clearances, and is expected to close by the end of the second quarter of 2024. Chris Koch, Chair, President and Chief Executive Officer, said "The sale of CIT aligns with our Vision 2030 strategy and represents a significant milestone in our strategic pivot from a diversified industrial portfolio of businesses to a premier pure play building products company. As we complete this strategic shift, we look forward to executing our commitment in Vision 2030 to delivering over $40 of adjusted EPS through our innovative building envelope products and solutions. ...We are further strengthening our capital foundation with the expected proceeds from the sale of CIT. When combined with our 15%+ free cash flow margin expected to continue through 2024 and beyond, this heightened financial strength affords us substantial flexibility to effectively execute our share repurchase program, pursue strategic building product acquisitions and other high-returning capital allocation priorities."
VAXX

Hot Stocks

08:06 EST Vaxxinity announces research collaboration with CTRND - Vaxxinity announced a research collaboration with the University of Florida's Center for Translational Research in Neurodegenerative Disease, CTRND, to support its work on the development of vaccines for neurodegenerative diseases. The research, funded by a grant from the state of Florida, aims to further the development of Vaxxinity's active immunotherapies to prevent and mitigate neurodegenerative diseases, having the potential to change the future of treatment by offering people an affordable and accessible therapeutic option. "Our collaboration with the University of Florida will support the continued development of vaccines for neurodegenerative diseases affecting millions of people worldwide," said Mei Mei Hu, CEO of Vaxxinity. "Our work with UF will drive a deeper understanding of how to neutralize toxic proteins in the brain implicated in diseases such as Alzheimer's and Parkinson's. This work builds upon years of research on our synthetic peptide technology platform to target endogenous proteins, and can help us to develop better candidates for neurodegenerative diseases in the future. We are not afraid to tackle the biggest challenges in science, and this collaboration is an important way we are advancing our vision to provide cheaper, safer, more convenient, and effective medicines for chronic disease to all."
IBM

Hot Stocks

08:05 EST IBM, GSMA partner to accelerate AI adoption and skills in telecom industry - The GSMA and IBM announced a new collaboration to support the adoption and skills of generative artificial intelligence in the telecom industry through the launch of GSMA Advance's AI Training program and the GSMA Foundry Generative AI program. The AI training program, the first in a new series of courses by GSMA Advance, seeks to prepare telco leaders for the AI-era and bridge skills gaps in the telecom industry, by equipping members with skills and knowledge to help effectively leverage Gen AI technologies utilizing watsonx, IBM's AI and data platform with AI assistants.
INMB

Hot Stocks

08:05 EST INmune Bio announces FDA removal of clinical hold for Alzheimer disease program - INmune Bio received correspondence from the FDA confirming that the full clinical hold on the Company's AD clinical trial program has been lifted. The Phase II trial is on track to enroll the last patient mid-2024. Top line data is expected approximately six months after the last patient is enrolled. "We are pleased with the FDA's response and will continue to work closely with the agency in anticipation of our Phase III AD program," said RJ Tesi, CEO of INmune Bio. "Our primary goal is to complete the Phase II program in 2024 followed by an end-of-Phase II meeting with the FDA in early 2025 to confirm our planned global Phase III trial that will include sites in the U.S., Canada, U.K., E.U. and Pacific Rim."
PXLW DIS

Hot Stocks

08:04 EST Disney and Pixelworks enter multi-year agreement for TrueCut Motion technology - Disney (DIS) and Pixelworks (PXLW) will bring a collection of TrueCut Motion graded titles to select home entertainment devices. These titles eliminate motion playback anomalies, while maintaining the desired brightness levels; all while preserving the authentic cinematic motion look and feel of the source. TrueCut Motion technology provides filmmakers with shot-by-shot motion grading tools, enabling new looks for storytelling, as well as correcting various motion anomalies in high contrast, very bright consumer device displays. TrueCut Motion technology then ensures that these creative choices are precisely mastered into the source material. TrueCut Motion is a registered trademark of Pixelworks.
SYY

Hot Stocks

08:03 EST Sysco expects to return $2.25B back to shareholders in 2024 - The company now expects to return approximately $2.25 billion back to shareholders in fiscal year 2024, raising share repurchase expectations from $750 million to $1.25 billion.
SEAS

Hot Stocks

08:03 EST SeaWorld to change name to 'United Parks & Resorts' on February 12 - SeaWorld Entertainment announced it will change its name to United Parks & Resorts, effective Feb. 12. The new name unites the company's world-class portfolio of seven brands across 13 parks in the United States and Abu Dhabi. The company's stock ticker symbol on the New York Stock Exchange will change from "SEAS" to "PRKS," with trading as PRKS to begin Feb. 13. The name change affects only the name of the parent company - SeaWorld Entertainment, Inc. The company's award-winning portfolio of parks - SeaWorld, Busch Gardens, Discovery Cove, Sesame Place, Water Country USA, Adventure Island, and Aquatica - retain their respective park names. "Our new company name, United Parks & Resorts Inc., better reflects that we have been, and will continue to be, a diverse collection of park brands and experiences. Each of our iconic parks, including the four SeaWorld parks in Orlando, San Antonio, San Diego and Abu Dhabi, will continue to operate under the same names our guests know and love. What also remains unchanged is our deep commitment to creating experiences that matter for our guests and inspiring them to help protect animals and the wild wonders of the world," said Marc Swanson, the company's CEO.
REKR

Hot Stocks

07:44 EST Rekor Discover chosen by NMDOT to conduct FHWA reporting - Rekor Systems announced its Urban Mobility division's cutting-edge Rekor Discover platform has been chosen by the New Mexico Department of Transportation to conduct Federal Highway Administration 13 bin vehicle class, count and speed data reporting for a phase one statewide deployment. Each of the initial 40 systems features Rekor Edge Series units utilizing advanced Edge AI to aggregate, transform, and securely deliver holistic traffic insights in real-time to Rekor Discover. This agreement follows the Company's standard MSRP pay-for-data pricing and the NMDOT will commence monthly payments as each system is brought online.
SNEX

Hot Stocks

07:42 EST StoneX Financial becomes Abaxx Exchange's first clearing, trading member - StoneX Financial and Abaxx Technologies announced that StoneX has become the first approved clearing and trading member of Abaxx's indirectly held, majority-owned Singapore-based exchange and clearinghouse, introducing centrally cleared, physically-deliverable futures contracts, and licensed as a Recognised Market Operator and Approved Clearing House with the Monetary Authority of Singapore. StoneX's clients will have access to Abaxx Exchange's suite of first-of-their-kind, physically- deliverable futures contracts, including liquefied natural gas, nickel sulphate, and carbon, from the first day of trading on Abaxx Exchange. This will enable StoneX clients to be the first market participants to benefit from Abaxx's market price discovery and enhanced risk management tools for energy transition-related commodities.
PR

Hot Stocks

07:42 EST Permian adds 500 accretive acres with majority ahead of 'drill-bit' in Q4 - Permian Resources Corporation announced a series of recent portfolio optimization transactions consisting of two bolt-on acquisitions, a sizeable acreage swap, a divestiture of non-core assets and additional grassroots acquisitions. "Since closing the Earthstone transaction, Permian Resources has added 14,000 net acres and 5,300 net royalty acres located in the core of the Delaware Basin at attractive valuations," said James Walter, Co-CEO of Permian Resources. "As a result of our portfolio management efforts over the past year, Permian Resources has more than replaced the approximately 150 wells included in its 2023 development schedule, effectively increasing inventory life. Going forward, we will continue our relentless focus on portfolio optimization, which is one of several key value drivers we believe differentiates Permian Resources." The Company recently executed two separate transactions to acquire a total of approximately 11,500 net leasehold acres and 4,000 net royalty acres located in Eddy County, New Mexico from undisclosed third-parties for a total consideration of approximately $175 million, or approximately $10,000 per net leasehold acre after adjusting for production value... Additionally, Permian Resources continues to be highly successful executing upon its ground game, consisting of smaller grassroots acquisitions. During the fourth quarter of 2023, the Company added approximately 500 net acres through over 35 grassroots leasing and working interest acquisitions. Notably, the majority of these acquisitions are executed ahead of the drill-bit, making them highly accretive...In the fourth quarter of 2023, Permian Resources closed the previously announced divestiture of legacy Earthstone's Eagle Ford assets for a purchase price of $67 million, which included approximately 1,000 barrels of oil equivalent per day of net production.
HCA

Hot Stocks

07:37 EST HCA Healthcare CFO Bill Rutherford to retire - HCA Healthcare is also announcing that Bill Rutherford has decided to retire as executive VP and CFO after a 34-year career with the company. Mike Marks, HCA Healthcare's current senior VP, finance, will succeed Rutherford as executive VP and CFO, effective May 1.
SWI TENB

Hot Stocks

07:36 EST SolarWinds names Brian Goldfarb new CMO - SolarWinds (SWI), a leading provider of simple, powerful, secure observability and IT management software, has named Brian Goldfarb as the company's new Chief Marketing Officer CMO ... In this role, Goldfarb will oversee all aspects of global marketing efforts for SolarWinds and its world-class observability, database, and service management solutions. Brian Goldfarb, Chief Marketing Officer, SolarWinds Goldfarb is a seasoned marketing executive who brings to the SolarWinds team more than 20 years of experience driving growth strategies at some of the world's largest and most respected technology companies. Most recently, he served as CMO of cybersecurity firm Tenable (TENB), where he expertly led the marketing team through rapid industry shifts while helping grow the company's revenue by nearly 50% during his tenure.
NEXCF GIC

Hot Stocks

07:36 EST Nextech3D.AI signs 3D model contract with Global Industrial - Nextech3D.AI (NEXCF) has signed a new 3D modeling contract with Global Industrial Company (GIC). This new contract has significant growth potential, as Global Industrial is an industry leader with 1.7+ million products in 21 industrial and commercial categories including; building supplies, storage and shelving, workbenches and shop desks and more.
VCIG

Hot Stocks

07:35 EST VCI Global awarded IPO contract in partnership with Legacy Corporate Advisory - VCI Global is awarded an initial public offering contract to list one of the largest Information Technology companies in Malaysia, providing cutting-edge cross-border technology solutions and services. A Memorandum of Understanding was inked yesterday between VCI Global and Legacy Corporate Advisory Sdn Bhd, solidifying their commitment to establishing a strategic alliance. This collaborative venture reflects a dedication to mutual cooperation, leveraging respective strengths and resources, and jointly exploring new market opportunities, particularly in relation to IPOs on stock exchanges in the United States. This partnership has resulted in their first IPO contract with the Malaysian-based IT Company, where synergies are achieved through the sharing of IPO and corporate consultancy knowledge and expertise between VCI Global and Legacy Corporate Advisory. The IT Company anticipates the completion of its planned IPO on Nasdaq by the end of 2024.
WPP

Hot Stocks

07:34 EST WPP sees FY24 LFL revenue less pass-through costs growth of 0-1% - "Company sees 2024 LFL revenue less pass-through costs growth of 0-1% ...2024 headline operating profit margin improvement of 20-40bps ...Our plans include annual cash investment of around GBP 250m in proprietary technology to support our AI and data strategy..Mark Read, CEO of WPP, said: "The past three years have demonstrated the power of brands, creativity and investment in marketing to drive growth for clients and to build significant value. Research demonstrates that those companies with the strongest brands deliver the highest returns to shareholders..."Our long-standing investments in AI, including our AI-powered platform, WPP Open, and our acquisition in 2021 of Satalia, a leading UK AI company, are at the heart of our competitive offer. An ongoing annual investment of GBP 250m in data and technology to support our AI strategy is included in our 2024 financial plans. "While we had to navigate a more challenging environment in 2023, we see strong future demand for our services and are confident we can accelerate our growth over the medium-term," the company noted in a release.
AVCNF

Hot Stocks

07:33 EST Avicanna, Ease Labs granted commercialization approval in Brazil - Avicanna announced ANVISA has granted commercialization approval of Ease Labs Pharma pharmaceutical preparation produced in Brazil containing Avicanna's Aureus branded active pharmaceutical ingredient. Ease Labs, a GMP-certified pharmaceutical company in Brazil, was granted approval from ANVISA to commercialize a pharmaceutical preparation product containing 2.5% of CBD and up-to 0.2% THC. This is the first product containing THC granted sanitary authorization under the RDC 327 and GMP certified manufacturing standards in Brazil. Ease Labs expects the product to be available in pharmacies with a medical prescription by March 2024. The full spectrum API is supplied by Avicanna's majority owned subsidiary Santa Marta Golden Hemp SAS, under a multi-year API supply agreement entered in 2021.
DFLI

Hot Stocks

07:32 EST Dragonfly Energy partners with John Lennon Educational Tour Bus - Dragonfly Energy Holdings announced a partnership with the John Lennon Educational Tour Bus, now powered by Battle Born Batteries. The Lennon Bus, a nonprofit mobile recording facility providing hands-on experiences for students of all ages, recently underwent a major overhaul with support from Dolby, Apple, Dragonfly Energy, and several more generous corporations. Transitioning the bus to lithium power takes the bus to a new level of sustainability, cost-savings, and improved experience with up to eight hours of runtime off the batteries alone, plus extended runtime with the availability of solar power.
NNXPF

Hot Stocks

07:32 EST NanoXplore expands capacity in Quebec plant - NanoXplore has increased the production capacity of its St-Clotilde, QC plant to meet an existing customer's need for increased graphene-enhanced SMC parts in an active program. This capacity expansion, which is part of its 5-year strategic plan and related to the SMC lightweighting initiative, begins immediately. This expansion, in two phases, will contribute $2M in incremental revenues during calendar 2024 and once fully scaled-up, is expected to contribute $8M to $10M annually beginning in calendar 2025. Moreover, a significant part of the capacity expansion costs will be assumed by the customer. Our customer has committed to purchase the additional equipment required for this program and consequently, the previously announced SMC lightweighting initiative capex of $30M to $35M will now be in a range of $25M to $30M. The Corporation is also pleased to announce the recent appointment of Pierre-Yves Terrisse as Vice-President of Corporate Development. In his role Pierre-Yves will be responsible for NanoXplore's function and strategy of investor relations, including articulating the Corporation's growth plan, business and financial objectives to the investment community. His network of institutional investors, sell-side financial community, combined with his expertise, will reinforce the Corporation's profile and strength. Finally, Pierre-Yves will engage and evaluate M&A opportunities, as well as participate in financing structure.
WPP

Hot Stocks

07:30 EST WPP sees FY24 operating profit margin 14.8%, equivalent to 15.0% - "2023 expected out-turn and 2024 outlook ...WPP will report 2023 results on February 22nd. We expect to report results in line with our guidance ranges with: 2023 LFL revenue less pass-through costs expected to be 0.9% consistent with guidance given at Q3 2023 of 0.5-1.0% ..2023 headline operating profit margin expected to be 14.8%, equivalent to 15.0% on a constant currency basis, which is at the top end of guidance of 14.8-15.0%." company said.
WPP

Hot Stocks

07:28 EST WPP boosts medium term growth in revenue less pass-through costs view - WPP is announcing the next phase of its strategy to capture the opportunities offered by AI, maximise the potential of creative transformation and deliver faster growth, higher margins and improved cash generation. Four strategic pillars support these goals: Deliver growth and structural cost savings as a result of the creation of VML and Burson and simplification of GroupM, unlocking scale advantages and further efficiency savings. Structural savings to deliver annualised net cost savings of c.GBP 125m in 2025, with 40-50% of that saving expected to be achieved in 2024. Associated restructuring cost of c.GBP 125m in 2024 ...Target c.GBP 175m gross savings from efficiency opportunities across both back office and commercial delivery which will be used to invest in growth and support delivery of our medium-term margin target...Updated medium-term targets: 3%+ LFL growth in revenue less pass-through costs; 16-17% headline operating profit margin...Adjusted operating cash flow conversion of 85%+1;Previous medium-term targets, outlined at WPP's Capital Markets Day in December 2020, were for 3-4% growth in revenue less pass-through costs including an M&A benefit of 0.5-1.0% annually; with a headline operating profit margin of 15.5-16.0%.
JBLU

Hot Stocks

07:25 EST JetBlue on track to deliver $75M savings via fleet modernization program by YE24 - JetBlue says that engine issues expected to drive significant aircraft ground time; currently seven aircraft out-of-service and expected to rise to ~13-15 by year-end. The company also added that the Structural Cost Program is at peak of expectations and expected to deliver $175M-200M in run-rate cost reduction through year-end 2024.
JBLU

Hot Stocks

07:24 EST JetBlue deferring $2.5B of planned CapEx from 2024-2027 to later in decade - Comments taken from Q4 earnings conference call presentation slides.
TSVT

Hot Stocks

07:23 EST 2seventy Bio names Chip Baird CEO, Vicki Eatwell CFO upon transaction closing - "Upon closing of the transaction with Regeneron (REGN), Chip Baird, chief operating officer, will become chief executive officer of 2seventy bio. The newly formed 2seventy bio leadership team will also include Vicki Eatwell, currently senior vice president of finance, who will become chief financial officer and Jessica Snow, senior vice president, quality and head of operations."
JBLU

Hot Stocks

07:23 EST JetBlue launching $300M of revenue initiatives in 2024 - "2024 is an important year of change for JetBlue and we are taking aggressive action, including launching $300M of revenue initiatives, to return to profitability and deliver value for our shareholders. We are moving with renewed rigor and discipline as we refocus our energy and play to our strengths, further deepening our unique competitive positioning," said Joanna Geraghty, JetBlue's president and COO.
WLDS

Hot Stocks

07:22 EST Wearable Devices to demonstrate spatial computing interaction for smart glasses - Wearable Devices announced its participation at SPIE Photonics West, taking place in at the Moscone Center San Francisco from Tuesday, January 30 to Wednesday, January 31, 2024. The Company will be located at booth 6124. At SPIE, Wearable Devices will demonstrate various new input and control functionalities available through the Mudra Band, a neural wristband to control digital devices using touchless hand gestures. The Mudra Band uses sensors to decipher the neural signal patterns of the wrist, translating the user's movement intent into a digital command for digital devices such as smart glasses, AR and VR headsets, smart TVs, and more. With this technology, users are able to navigate, select and interact with elements of their devices using comfortable and familiar gestures such as pinch, swipe, pinch and hold, all while remaining in relaxed body postures. The Company will also present the new Mudra Development Kit and its various input modalities, which enhance the user experience of smart glasses through spatial gesture input. Each MDK modality can be specifically tailored to offer the optimized user experience for the Graphical User Interface: A pointing device functionality to control a cursor for rich displays, a directional pad functionality using swipes for discrete interaction, and a peripheral controller functionality for tailored-custom user gestures for practical eyewear devices.
MBOT

Hot Stocks

07:20 EST Microbot Medical announces settlement, release agreement - Microbot Medical has signed a Settlement Agreement and Release with Empery Asset Master Ltd., Empery Tax Efficient, LP, Empery Tax Efficient II, LP, Hudson Bay Master Fund Ltd. that resolves all claims asserted against the Company by these entities in a lawsuit filed in 2020 relating to a June 2017 securities purchase agreement. All of the cash payable to the plaintiffs in the settlement, representing over half of the settlement amount, will be covered by Microbot's insurance carrier. This arrangement ensures that the settlement will not impact the company's cash position or its balance sheet.
TSVT...

Hot Stocks

07:17 EST 2seventy Bio to focus on Abecma commercialization with Bristol Myers Squibb - 2seventy bio ( TSVT) , announced that it is transforming the Company to focus exclusively on the commercialization and development of Abecma or idecabtagene vicleucel, its BCMA-targeted CAR T therapy for multiple myeloma. The actions announced follow an extensive evaluation of the Company's business and strategic alternatives by its Board of Directors. As a result of this strategic re-alignment, the Company expects annual savings of approximately $150 M in 2024 and approximately $200M in 2025, inclusive of one-time restructuring costs of approximately $8M. The Company expects to have extended cash runway beyond 2027...In connection with the Company's strategic re-alignment, and as announced in a separate press release today by Regeneron Pharmaceuticals (REGN), the Company has entered into an asset purchase agreement with Regeneron to sell the Company's oncology and autoimmune research and development programs, clinical manufacturing capabilities, and related platform technologies...2seventy bio, in partnership with Bristol Myers Squibb (BMY) , is taking actions to return Abecma to commercial growth in 2024. The Company expects a final PDUFA action following the planned Oncologic Drugs Advisory Committee meeting on the supplemental Biologics License Application sBLA for Abecma based on the KarMMA-3 clinical study, which, if approved, would expand the label into the larger third line setting. 2seventy bio and BMS are expanding its Abecma site footprint to enable more patients to access the treatment. This includes educating physicians on treatment sequencing and the emerging data supporting the use of BCMA-directed CAR Ts before other BCMA-targeted therapies, and competitively differentiating Abecma's real-world safety, efficacy and product reliability and predictability profile. The Company will continue to support the quality control of the lentiviral vector manufacturing for Abecma and support the transition to suspension LVV which will deliver additional efficiencies and cost savings.
CMMB

Hot Stocks

07:16 EST Chemomab Therapeutics' CM-101 shows clinical potential in sclerosing cholangitis - Chemomab Therapeutics announced publication of proteomic analyses that further demonstrate the role of the soluble protein CCL24 in driving pathologies associated with the rare fibrotic liver disease primary sclerosing cholangitis. The new studies reinforce existing evidence showing that Chemomab's first-in-class CCL24-neutralizing antibody CM-101 can interrupt these destructive processes. The studies confirmed the exclusive association of CCL24 with fundamental PSC mechanisms, with no similar association seen with two other related proteins sharing the same receptor, emphasizing CCL24's unique potential as a target for PSC therapies. CM-101 has Orphan Drug designation for PSC in the U.S. and the European Union and was recently awarded Fast Track designation by the FDA for the treatment of PSC in adults.
ALAR

Hot Stocks

07:15 EST Alarum's NetNut enhances data collection offering - Alarum Technologies announces that NetNut Ltd., its wholly owned subsidiary, has recently launched its new and innovative Website Unblocker. The new product joins NetNut's suite of Data Collection and Analysis tools, further solidifying NetNut's leadership position in the data collection and labelling market.
ITRM

Hot Stocks

07:13 EST Iterum Therapeutics' sulopenem shows positive results in urinary infections - Iterum Therapeutics announced positive topline results from its REASSURE Phase 3 clinical trial comparing oral sulopenem to oral Augmentin in adult women with uncomplicated urinary tract infections. With the positive data from this trial, Iterum plans to resubmit its New Drug Application for oral sulopenem for the treatment of uUTI in Q2. At the same time, Iterum will focus on selling, licensing, or otherwise disposing of its rights to sulopenem with the goal of maximizing value for its stakeholders. Results demonstrate that oral sulopenem was non-inferior to Augmentin with respect to the trial's primary endpoint, overall response at the test-of-cure visit in the microbiological-modified-intent-to-treat susceptible population. Oral sulopenem showed overall success in 61.7% of patients compared to 55.0% for Augmentin, demonstrating statistically significant superiority of oral sulopenem versus Augmentin. Both oral sulopenem and Augmentin were well tolerated in this study with discontinuations due to adverse events occurring in less than1% of patients on both regimens. No serious adverse events were reported in patients receiving oral sulopenem, while five SAEs occurred in patients receiving Augmentin, with no drug-related SAEs. The safety profile for oral sulopenem was consistent with those observed in each of the previously conducted Phase 3 trials, with no new safety signals noted beyond those associated with beta-lactams. Iterum expects that the FDA will complete its review and take action six months from the date the FDA receives the resubmitted NDA, or during Q4.
CANF

Hot Stocks

07:11 EST Can-Fite BioPharma expands out licensing transaction with Ewopharma - Can-Fite BioPharma announced that it has expanded its out licensing transaction with Ewopharma AG. to include the pancreatic cancer indication of Can-Fite. During 2021, Can-Fite entered into an exclusive distribution agreement for Piclidenoson with Switzerland-based Ewopharma AG for the treatment of psoriasis and Namodenoson for the treatment of hepatocellular carcinoma, or HCC, and nonalcoholic steatohepatitis, or NASH. Under the terms of the distribution agreement, Ewopharma AG paid Can-Fite an upfront payment of $2.25M with up to an additional $40.45M, payable upon the achievement of regulatory and sales milestones, plus 17.5% royalties on net sales. In exchange, Ewopharma AG received the exclusive right to market and sell Piclidenoson in Central Eastern European countries and Namodenoson in CEE countries and Switzerland. Ewopharma AG exercised its right to expand the distribution agreement to include the indication of pancreatic cancer and the transaction terms of the distribution agreement are applicable to such indication. Ewopharma is a pharmaceutical sales and marketing firm that helps pharma companies access markets in CEE and Switzerland. In addition to Can-Fite, Ewopharma AG has distribution agreements with many leading healthcare companies including Eisai and Biogen.
OSK

Hot Stocks

07:10 EST Oshkosh announces 12.2% boost in dividend to 46c per share - Oshkosh announces a quarterly cash dividend of $0.46 per share, representing a 12.2 percent increase, which marks the 10th consecutive year in which we have increased our dividend by double digits," said management.
TARO

Hot Stocks

07:08 EST Taro Pharmaceutical shareholder Krensavage states opposition to takeover bid - Taro Pharmaceutical shareholder Krensavage Asset Management sent a message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical. The message states, among other things: "As the largest minority shareholder1 of Taro Pharmaceutical Industries, Krensavage Asset Management remains opposed to Sun Pharmaceutical Industries Ltd.'s inadequate bid to take Taro private...Sun on May 26 disclosed a $38 lowball bid for Taro. Sun's new offer amounts to a 9% discount to the value of Taro's tangible assets, primarily $35 a share of net cash. Including real estate and other hard assets, Taro's liquidation value likely approaches $47 a share. Sun is valuing Taro at $310M, net of cash, for a business that generated $2.4B of cash in the 10 years ended March 31, the close of Taro's most-recent fiscal year. We question if the special committee Taro appointed to consider Sun's bid is neglecting its responsibility by embracing a transaction that fails to recognize Taro's carcass value, much less its ability to generate cash. None of Taro's board members own shares of the company...Taro's bankers have lowballed before...Sun can pay more. Sun is offering, net of Taro's cash, $67M for the roughly 8.1 million Taro shares it doesn't own. In December 2019, Taro paid $91 a share to repurchase its stock in a tender offer - more than twice Sun's current bid. Sun requires approval of the majority of Taro's minority shareholders. Unless Sun acknowledges Taro's value, we continue to decline to support the transaction".
NB

Hot Stocks

07:08 EST NioCorp enters collaboration with Brunel University London - NioCorp Developments announced that the Company has entered into an agreement with London-based Brunel University London to develop innovative aluminum-scandium alloys and applications for use in the automotive sector. NioCorp has joined with the Brunel Centre for Advanced Solidification Technology to develop a range of innovative aluminum alloys for the automotive sector. These alloys will utilize scandium to enhance the performance of aluminum components in order to facilitate: Vehicle light weighting - developing aluminum-scandium alloys that reduce weight, increase automobile efficiencies, and reduce emissions; Recycling - utilizing the performance-enhancing attributes of scandium to increase recyclability, creating sustainable low-carbon circular supply chains; and Cost Reduction - reducing manufacturing costs and waste through utilizing scandium to increase the strength, ductility, weldability, durability, surface finish, and corrosion resistance of critical aluminum components.
TLRY

Hot Stocks

07:07 EST Tilray's Breckenridge Distillery, Brewery announce limited release whiskey - Breckenridge Distillery and Breckenridge Brewery, two subsidiaries of Tilray Brands, announced the fourth edition of Sexy Motor Oil, a limited release collaboration barrel-aged whiskey alongside a new collaboration, a whiskey-barrel aged beer, of the same name. "Our collaboration with Breckenridge Brewery has deepened over the years, rooted in a mutual commitment to craftsmanship and innovation," said Bryan Nolt, founder and CEO of Breckenridge Distillery. "Sexy Motor Oil represents the harmonious blend of our expertise and the embodiment of our shared values."
ENGN

Hot Stocks

07:07 EST enGene names Lee Giguere as Chief Legal Officer and Corporate Secretary - enGene announced the appointment of Lee Giguere as Chief Legal Officer and Corporate Secretary. Giguere previously served as Chief Legal Officer and Secretary of Obsidian Therapeutics, a clinical-stage cell and gene therapy company.
XTRAF

Hot Stocks

07:06 EST Xtract One selected by Wisconsin Center District to secure Baird Center - Xtract One Technologies announced its partnership with the Wisconsin Center District o implement the Company's SmartGateway system at all entrances of Baird Center, Wisconsin's largest convention center. Baird Center, owned and operated by WCD, is currently undergoing a $456 million expansion set to unveil in May 2024. This three-year partnership serves as the Company's first with a convention center, and a validation of the continuing innovation to deliver advanced weapons detection for the broadest set of weapons, without alerting on increasing levels of clutter typical of patrons at convention centers, commercial properties, and schools.
NVTA BBIO

Hot Stocks

07:06 EST Invitae partners with BridgeBio for discovery of rare disease therapeutics - Invitae (NVTA) announced a partnership with BridgeBio Pharma (BBIO) designed to advance genetics-based drug discovery for rare diseases. The goal of the collaboration is to generate new insights focused on genetic modifiers and the discovery of novel therapeutic targets for rare diseases and other unmet medical needs. The agreement expands upon the longstanding partnership between the two companies to combine the strengths of BridgeBio's deep expertise in rare disease research and development of therapeutics, and Invitae's rare disease enriched dataset and analytical capabilities. Invitae has provided clinical testing for more than 4M patients, generating an extensive dataset that is uniquely positioned to deepen insights on patients with genetic-driven disease.
DPRO

Hot Stocks

07:06 EST Draganfly to develop tactical multi-drop payload system for MMS Products - Draganfly announces that it has been selected by MMS Products to develop a drone-based tactical multi-drop payload system. This drone payload system is designed explicitly for tactical multi-drop and ISR operations. The highlight of this development is the integration with MMS Products' Mjolnir, a highly configurable delivery device renowned for its versatility and effectiveness in various operational scenarios. This optimization with the Commander 3XL drone will enhance the performance and efficiency of both technologies, resulting in a robust turnkey tactical solution. "This development marks a significant step in professional and scalable small drone tactical capability, merging the expertise of MMS Products with Draganfly's expertise in drone development," said Cameron Chell, President and CEO of Draganfly. "We are thrilled to develop this system for MMS and be their system provider of choice going forward in their rapidly expanding market. The tactical multi-drop system is expected to bring new levels of efficiency, safety, and effectiveness to operations that require such technology, including military, demining, and specialized industrial applications."
KURA

Hot Stocks

07:04 EST Kura Oncology reports preliminary ziftomenib combination data - Kura Oncology reported preliminary clinical data from the first 20 patients in KOMET-007, a Phase 1 dose-escalation trial of the Company's potent and selective menin inhibitor, ziftomenib, in combination with standards of care, including cytarabine/daunorubicin and venetoclax/azacitidina, in patients with NPM1-mutant and KMT2A-rearranged acute myeloid leukemia, AML. Continuous daily dosing of ziftomenib at 200 mg QD has been well tolerated and the safety profile consistent with features of underlying disease and backbone therapies. No differentiation syndrome events of any grade were reported, and no dose-limiting toxicities, evidence of QTc prolongation, drug-drug interactions or additive myelosuppression were observed. As of the data cutoff on January 11, 2024, all newly diagnosed patients treated with ziftomenib and 7+3 achieved a complete remission with full count recovery, for a CR rate of 100%, including four patients with NPM1-m AML and one patient with KMT2A-r AML. The overall response rate among R/R patients treated with ziftomenib and ven/aza was 53%. Among all patients treated with ziftomenib and ven/aza, 40% received prior treatment with a menin inhibitor. The CR/CRh2 rate in patients who were menin inhibitor naive was 56% including 60% in patients with NPM1-m AML and 50% in patients with KMT2A-r AML. The ORR in patients who received prior venetoclax was 40%, including 60% in patients with NPM1-m AML. As of the data cutoff, 80% of patients remain on trial, including 100% of all NPM1-m patients
SSTK

Hot Stocks

07:04 EST Shutterstock raises quarterly dividend 11% to 30c from 27c per share - The dividend is payable on March 14 to stockholders of record at the close of business on February 29.
REGN TSVT

Hot Stocks

07:04 EST Regeneron forms Regeneron Cell Medicine amid acquisition of 2seventy platforms - Regeneron Pharmaceuticals (REGN) announced the formation of Regeneron Cell Medicines based on an agreement with 2seventy bio (TSVT) to acquire full development and commercialization rights to its pipeline of investigational novel immune cell therapies, along with its discovery and clinical manufacturing capabilities. 2seventy bio employees who support the acquired programs will join Regeneron Cell Medicines, a newly formed research & development unit to advance cell therapies and combination approaches in oncology and immunology. In 2018, Regeneron and bluebird bio entered into an agreement to leverage their complementary technologies to discover novel cell therapy approaches to address cancer. Under the original agreement, Regeneron had the right to opt-in to a co-development/co-commercialization arrangement for collaboration targets. Under the terms of the new agreement, Regeneron will acquire full development and commercialization rights of 2seventy bio's preclinical and clinical stage pipeline and will assume ongoing program, infrastructure and personnel costs related to these programs. There will be an upfront payment of $5 million and a single milestone payment from Regeneron to 2seventy bio for the first major market approval of the first approved product. Regeneron will pay 2seventy bio a low single-digit percent royalty on revenues generated by the products. The transaction is expected to close in the first half of 2024 subject to certain closing conditions including SEC-filings required by 2seventy bio and landlord consent of the sublease agreements. To realize the full potential of these programs and capabilities, Regeneron Cell Medicines has been created to advance the next generation of cell therapies and explore combinations with Regeneron's proprietary antibodies and bispecifics. An estimated 150 employees from 2seventy bio will transition to Regeneron to continue their work on cell therapy programs and will remain located in Cambridge, MA and Seattle, WA. Philip Gregory, D.Phil., currently the Chief Scientific Officer of 2seventy bio, will be appointed Senior Vice President and Head of Regeneron Cell Medicines upon closing of the transaction.
BMY

Hot Stocks

07:02 EST Bristol Myers' application for Breyanzi in lymphoma accepted in U.S. and Japan - Bristol Myers announced three regulatory acceptances from the FDA and Japan's Ministry of Health, Labour and Welfare - MHLW - for Breyanzi. In the U.S., the FDA has accepted the company's two supplemental Biologics License Applications for Breyanzi to expand into new indications to include the treatment of adult patients with relapsed or refractory follicular lymphoma and relapsed or refractory mantle cell lymphoma after a Bruton tyrosine kinase inhibitor. The FDA has granted both applications Priority Review and assigned a Prescription Drug User Fee Act goal date of May 23 for Breyanzi in relapsed or refractory FL and May 31 for Breyanzi in relapsed or refractory MCL. Japan's MHLW has also accepted Bristol Myers Squibb's supplemental New Drug Application for Breyanzi for the treatment of relapsed or refractory FL. In relapsed or refractory FL, the applications for Breyanzi in the U.S. and Japan are based on results from the TRANSCEND FL study.In the study, Breyanzi demonstrated high rates of complete responses. In relapsed or refractory MCL, the application for Breyanzi in the U.S. is based on results from the MCL cohort of the TRANSCEND NHL 001 study, in which Breyanzi demonstrated statistically significant and clinically meaningful responses in heavily pre-treated patients, with the majority of patients achieving a complete response. A sBLA for Breyanzi for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma who have received a prior BTKi and B-cell lymphoma 2 inhibitor is also currently under Priority Review with the FDA with an assigned target action date of March 14.
KXIN

Hot Stocks

07:01 EST Kaixin Auto announces export intention order of 1,000 EVs - Kaixin Auto Holdings has received an intention order to export 1,000 new energy vehicles in SKD mode to New Power Auto in Myanmar. The first batch of 100 vehicles will be shipped to Myanmar shortly. Moreover, Kaixin has also obtained a five-year authorization from the Myanmar company as its strategic partner for the export of complete and SKD vehicles from China.
BDX

Hot Stocks

06:56 EST Becton Dickinson, Techcyte enter collaboration - Becton Dickinson and Techcyte announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and precancer using whole-slide imaging.
ACCO

Hot Stocks

06:56 EST Acco Brands announces cost reduction program - Acco Brands announces a multi-year restructuring and cost savings program, with anticipated annualized pre-tax cost savings of at least $60M. The program incorporates initiatives to simplify and delayer the Company's operating structure and reduce costs through headcount reductions, supply chain optimization, global footprint rationalization, and better leveraging of our sourcing capabilities. As a result of these actions, the Company will improve its speed of execution and bring key leaders closer to the customers. In connection with this program, the Company will file a Form 8-K with the SEC disclosing its restructuring charges. "The actions we are announcing today will better position the Company for long-term sustainable profitable growth. The cost reduction actions, as well as a renewed focus on innovation and new product development, will provide fuel for reinvestment and an improved growth trajectory for the long-term. During 2023, we were able to restore the Company's margin profile and strengthen the balance sheet despite a slow demand environment. Our preliminary results indicate that we ended the year with reported sales and cash flows above our previously communicated outlook. I remain confident in the long-term growth prospects of the Company given our geographically diverse operating platform and our collection of leading brands" said ACCO Brands' President and Chief Executive Officer, Tom Tedford. The Company will operate and report under two segments. The Americas reportable segment will include the U.S., Canada, Brazil, Mexico and Chile and the International reportable segment will include EMEA, Australia, New Zealand and Asia. The Company will report on this basis for the fiscal year commencing January 1, 2024. As a result of the segment realignment, effective January 1, 2024, Cezary Monko has been appointed Executive Vice President and President of the International segment and Patrick Buchenroth, has been appointed Executive Vice President and President of the Americas segment. These leaders have a long-established, successful history with the Company.
MSCI

Hot Stocks

06:49 EST MSCI sees 2024 CapEx $95M-$105M - Sees 2024 adjusted EBITDA expense $1.13B-$1.160B. Sees 2024 net cash $1.33B-$1.38B.
PFE

Hot Stocks

06:49 EST Pfizer sees FY24 revenue of $8B from Comirnaty/Paxlovid - Sees $8B in anticipated revenues for Comirnaty and Paxlovid (approximately $5B and $3B, respectively), approximately $3.1B in anticipated revenues from Seagen and approximately $1B related to the reclassification of Pfizer's royalty income from Other (Income)/Deductions into the Revenue line.
MPC

Hot Stocks

06:49 EST Marathon Petroleum sees FY24 capital spending $1.25B - MPC's standalone capital spending outlook for 2024 is $1.25B. Approximately 65% of overall spending is focused on growth capital and 35% on sustaining capital. MPC's $825M of growth capital is focused on opportunities that enhance margins and reduce cost.
CLRB

Hot Stocks

06:45 EST Cellectar Biosciences enrolls first patient in pediatric glioma Phase 1b study - Cellectar Biosciences announced the first patient has been enrolled in its Phase 1b clinical trial evaluating iopofosine I 131, a novel phospholipid radiotherapeutic conjugate, in pediatric patients with relapsed or refractory malignant high-grade gliomas, or pHGG. The open-label study will assess two dosing regimens to identify the optimal iopofosine I 131 Phase 2 recommended dose and schedule in pHGG patients and evaluate safety and tolerability. The study is supported by a $2M Fast Track SBIR grant from the National Institute of Health's National Cancer Institute, which was awarded based in part on the promising Phase 1a trial data.
TRMB

Hot Stocks

06:41 EST Trimble announces $800M stock repurchase program - The company also announced that the board has authorized a common stock repurchase authorization of up to $800M, which replaces the company's existing authorization and goes into effect immediately. Trimble expects to utilize a significant amount of the authorization in 2024. The company plans to host an investor day in the second half of 2024 where it will provide an update of the company's margin target in the context of the new segment reporting structure.
JBLU

Hot Stocks

06:40 EST JetBlue reports Q4 CASM down 2.4% y/y - Operating expense per available seat mile for the fourth quarter of 2023 decreased 2.4% year-over-year. Operating expense per available seat mile, excluding fuel and related taxes, other non-airline operating expenses, and special items for the fourth quarter of 2023 increased 7.6% year-over-year. Average fuel price in the fourth quarter of 2023 of $3.08 per gallon, including hedges.
TRMB...

Hot Stocks

06:40 EST Trimble names F5 Networks CPO, Keysight Technologies chairman to board - Trimble (TRMB) announced the appointment of Kara Sprague and Ron Nersesian to its board of directors, effective February 5. Sprague is the executive VP and chief product officer at F5, Inc. (FFIV) and Nersesian is the chairman of the board of directors of Keysight Technologies (KEYS), and formerly served on Trimble's board of directors from November 2011 through May 2021.
JBLU

Hot Stocks

06:39 EST JetBlue sees Q1 CASM ex-fuel up 9%-11% y/y - Sees FY24 CASM ex-fuel up mid-to-high single digits. Sees FY24 adjusted operating margin approaching breakeven. Sees FY24 CapEx ~$1.6B. Sees Q1 CapEx ~$250M.
JBLU

Hot Stocks

06:37 EST JetBlue sees Q1 ASMs (6%)-(3%) y/y - Sees FY24 ASMs down low single digits.
VRTX

Hot Stocks

06:34 EST Vertex Pharmaceuticals reports positive Phase 3 results of VX-548 in acute pain - Vertex Pharmaceuticals announced positive results from its Phase 3 program for the selective NaV1.8 inhibitor, VX-548, in the treatment of moderate-to-severe acute pain. The Phase 3 program included two pivotal trials, one following abdominoplasty surgery and one following bunionectomy surgery, as well as a single arm safety and effectiveness study. Treatment with VX-548 following abdominoplasty or bunionectomy surgery resulted in a statistically significant improvement on the primary endpoint of the time-weighted sum of the pain intensity difference from 0 to 48 hours vs. placebo as well as a clinically meaningful reduction in pain from baseline at 48 hours in both studies. Neither trial met the key secondary endpoint of time to meaningful pain relief defined as greater than or equal to2-point reduction in NPRS from baseline compared to placebo. VX-548 had a more rapid onset to meaningful pain relief than placebo in both the abdominoplasty and bunionectomy trials. Other secondary endpoints in both trials were generally consistent with the primary endpoint. The Phase 3 single arm safety and effectiveness study evaluated treatment with VX-548 across a broad range of other surgical and non-surgical acute pain conditions and demonstrated favorable safety and tolerability. VX-548 was safe and well tolerated in all three Phase 3 studies. Vertex plans to submit a New Drug Application to the FDA by mid-2024 with the goal of achieving a broad label in moderate-to-severe acute pain. VX-548 has secured Breakthrough Therapy and Fast Track designations in the U.S. for acute pain. In addition, Vertex seeks to achieve a broad label in peripheral neuropathic pain. Vertex has also initiated a Phase 2 peripheral neuropathic pain study of VX-548 in patients with painful lumbosacral radiculopathy, or LSR, which is pain caused by impairment or injury to nerve roots in the area of the lumbar spine.
PHM

Hot Stocks

06:32 EST PulteGroup CEO says 'tremendous momentum heading into 2024' - "PulteGroup's strong fourth quarter financial results complete a record setting year, while the 57% increase in net new orders provides tremendous momentum heading into 2024," said Ryan Marshall, PulteGroup President and CEO. "For the full year, PulteGroup generated nearly $16 billion in revenues and net income of $2.6 billion, while delivering a return on equity* of 27.0% and returning over $1.1 billion to shareholders through stock repurchases and dividends. "As the fourth quarter progressed, we experienced a significant increase in buyer activity as interest rates moved lower, resulting in December being the highest sales month of the quarter. With expectations for interest rates to remain lower in 2024, we are optimistic that improved affordability dynamics will continue attracting buyers into the market. "After multiple years of variable macroeconomic activity, expectations are that 2024 can be a year of increased homebuying demand given a strong job market, lower interest rates and a limited inventory of existing homes. With a ready supply of homes and lots, I believe PulteGroup is extremely well positioned to capitalize on such market conditions as we seek to grow our business, while delivering strong cash flow and high returns."
PHM

Hot Stocks

06:31 EST PulteGroup reports Q4 net new orders increased 57% to 6,214 homes - Closings of 7,615 Homes Drove Home Sale Revenues of $4.2B. Home Sale Gross Margin of 28.9%. Unit Backlog of 12,146 Homes with a Value of $7.3B.
PHM

Hot Stocks

06:25 EST PulteGroup raises share repurchase authorization by $1.5B - PulteGroup announced that its Board of Directors has approved a $1.5B increase to the company's share repurchase authorization. This increase brings the company's total share repurchase authorization to $1.8B.
UPS

Hot Stocks

06:12 EST UPS falls 5% to $150.00 after FY24 revenue guidance misses estimates
BEEM

Hot Stocks

06:09 EST Beam Global appoints former Nuclear Navy Officer Mark Myers as COO - Beam Global announced that former Nuclear Navy Officer Mark Myers has joined the Beam Global executive team as COO. Myers has over 20 years of experience leading lean transformations in design, manufacturing and logistics. Previous senior management experience includes Thyssenkrupp Automotive, General Atomics, McKinsey & Co. and a leadership role as an officer in the United States Nuclear Navy. The COO role has not previously been filled at Beam Global.
ECL F

Hot Stocks

06:06 EST Ecolab selects Ford Pro to accelerate North American EV fleet - Ecolab (ECL) selected Ford Pro, Ford's (F) commercial division, to accelerate the electrification of its sales and service fleet, targeting complete North American fleet electrification by 2030. Ecolab's and Ford's business relationship, forged nearly 100 years ago, is expanding on the heels of a new commitment to create positive impacts, progress toward carbon neutrality and advance sustainable growth. Electrification of Ecolab's North American fleet begins in California with the conversion of its sales and service vehicles to EVs by 2025. Ecolab will purchase and deploy more than 1,000 Ford F-150 Lightning Pro trucks and Mustang Mach-E SUVs, creating what is anticipated to be the largest all-electric sales and service fleet in California. Ford Pro offers a full suite of charging and telematics software that Ecolab will use to help the business maximize vehicle performance and fleet productivity. The move to EVs is a crucial step in Ecolab's efforts to achieve net-zero emissions globally by 2050.
CALB BCAL

Hot Stocks

06:06 EST California BanCorp and Southern California Bancorp enter merger agreement - Southern California Bancorp (BCAL), the holding company for Bank of Southern California, and California BanCorp (CALB), the holding company for California Bank of Commerce, jointly announced the execution of a definitive merger agreement, pursuant to which the companies will combine in an all-stock merger valued at approximately $233.6M, or $26.54 per share of California BanCorp. The transaction aims to create a premier California financial institution with approximately $4.6B in assets in a merger of equals that adds complementary business lines and diversified lending verticals to each client base. Under the terms of the definitive agreement, which has been unanimously approved by the boards of directors of Southern California Bancorp and California BanCorp, each outstanding share of California BanCorp common stock will be exchanged for the right to receive 1.590 shares of Southern California Bancorp common stock. As a result of the transaction, Southern California Bancorp shareholders will own approximately 57.1% of the outstanding shares of the combined company and California BanCorp shareholders will own approximately 42.9% of the outstanding shares of the combined company. The companies will evaluate rebranding with new names and logos for the combined company and bank at the close of the transaction. The combined company's common stock will continue to trade on the Nasdaq. Corporate headquarters will be located in San Diego, Calif. The combined company's Southern California footprint will include Bank of Southern California's 13 branches that serve Los Angeles, Orange, San Diego, and Ventura counties, and the Inland Empire. The combined company's Northern California footprint will include the California Bank of Commerce branch in Contra Costa County and its four loan production offices serving Alameda, Contra Costa, Sacramento, and Santa Clara counties. The combined company's Board of Directors will consist of six directors from Southern California Bancorp and six from California BanCorp. A lead independent director will be appointed after closing. David Rainer, Chairman of Southern California Bancorp, will serve as Executive Chairman of the combined company, bank and boards. Steven Shelton, CEO of California BanCorp, will serve as CEO and director of the combined company and the combined bank. Richard Hernandez, President of Southern California Bancorp, will serve as President of the combined company and combined bank. Thomas Sa, CFO and COO of California BanCorp will serve as COO of the combined company and combined bank. Thomas Dolan, CFO and COO of Southern California Bancorp will serve as CFO of the combined company and Chief Strategy Officer of the combined bank. The transaction is expected to close in 3Q24, subject to satisfaction of customary closing conditions, including receipt of required regulatory approvals and approvals from Southern California Bancorp and California BanCorp shareholders.
UPS

Hot Stocks

06:02 EST UPS raises quarterly dividend to $1.63 per share - For the 15th consecutive year, the UPS Board of Directors has approved an increase to the company's quarterly dividend. UPS will pay a first-quarter 2024 dividend of $1.63 per share on all outstanding Class A and Class B shares. The dividend is payable March 8 to shareowners of record on February 20.
MSFT AAPL

Hot Stocks

05:55 EST Microsoft executive says Apple's App Store rules 'a step in the wrong direction' - Apple's (AAPL) new plan to comply with the European Union's tech regulations is a "step in the wrong direction," said Xbox (MSFT) president Sarah Bond in a post on X, formerly known as Twitter. "We hope they listen to feedback on their proposed plan and work towards a more inclusive future for all." Reference Link
NUTX

Hot Stocks

05:36 EST Nutex Health announces full payoff of Yorkville Advisors, to close two hospitals - Nutex Health announced full payoff of Yorkville Advisors and a new streamlined strategic plan. Nutex has paid off in full the remaining outstanding balance of $2.7M under the pre-paid advance agreement, in lieu of future stock issuances at the discretion of Yorkville Advisors. The company believes that this will mitigate the recent downward pressure on its share price and strengthen Nutex Health's financial position. The company has made the strategic decision to close two underperforming hospitals: SE Texas ER & Hospital in Humble, Texas, and Coppell ER in Coppell, Texas. The combined annual cash flow savings from closing both facilities is expected to be approximately $5M. This strategic move ensures a more focused allocation of resources and underscores our dedication to financial sustainability and profitability. The full effects of the new operating cost structure are expected to be in place by the third quarter FY24. Additionally, the company announced the following developments: On January 25, 2004, Nutex Health closed on an offering of $10M of shares of common stock and warrants with a health care focused institutional investor. This capital infusion will play a role in financing the operations of several of the new micro hospitals. Effective January 1, in consultation with the Departments of Labor and Health and Human Services, the Internal Revenue Service announced the annual increase that health plans must apply to the calculation of the qualifying payment amount for insurance reimbursements to account for inflation from 2023 to 2024. Under the No Surprises Act, QPAs are calculated based on median contracted rates for the same or similar services as they existed in 2019. Treasury Regulations direct the IRS to anchor the annual inflationary update in the Consumer Price Index for All Urban Consumers. In Notice 2024-1, the IRS directs health plans to update QPAs in 2024 by an increase of 5.4% over 2023 QPAs. Alternatively, to update 2023 rates, health plans may return to the original 2019 calculation and apply a cumulative update factor to account for the IRS inflationary updates from 2019 to 2024. Under that approach, the cumulative update that must be applied to 2019 base year rates is 20.9%. The company is on track to opening five new micro hospitals in 2024, strategically located in growth markets including Green Bay, Wisconsin, Milwaukee, Wisconsin, Tampa, Florida, San Antonio, Texas and Coeur d'Alene, Idaho.
SVM

Hot Stocks

05:25 EST Silvercorp Metals satisfies NYSE condition in connection with OreCorp offer - Silvercorp Metals announced that it has received authorization of its supplemental listing application from the NYSE American in connection with Silvercorp's off-market takeover offer for all of the shares of OreCorp not already owned by Silvercorp for consideration comprising 0.0967 common shares of Silvercorp and A$0.19 cash per OreCorp share, as described in the company's news release of December 26, 2023. Silvercorp will now proceed with issuing a notice in accordance with the Australian Corporations Act that the "Stock Exchange Approvals" condition to the Silvercorp Offer has been satisfied. As previously announced on January 24, the company received conditional approval from the Toronto Stock Exchange. Final TSX approval is subject to the company meeting certain customary conditions required by the TSX. The company anticipates that the next significant step towards completing the transaction will be a merger-approval decision in relation to the Silvercorp offer from the Tanzanian Fair Competition Commission, or FCC. In early November 2023, Silvercorp obtained FCC approval in respect of the then proposed scheme of arrangement with OreCorp. Given this existing approval, the minimal additional documentation which OreCorp and Silvercorp were required to provide to the FCC in the updated application and recent meetings with relevant Tanzanian authorities, Silvercorp anticipates that it is well positioned to receive the further FCC confirmation and/or approval in respect of the Silvercorp Offer within an expedited timeframe. As an example, the FCC was willing to reduce the required public notice period from 14 days to 7 days in light of the Existing Approval. Silvercorp currently expects to receive the FCC decision by mid-February 2024 and will provide further updates on the Transaction as appropriate. Silvercorp notes that the OreCorp board has provided a unanimous recommendation in favour of the Silvercorp Offer, in the absence of a superior proposal and subject to the independent expert's report concluding, and continuing to conclude, that the Silvercorp Offer is reasonable to OreCorp shareholders.
HCM

Hot Stocks

05:18 EST Hutchmed announces marketing approval of Elunate in Hong Kong - Hutchmed announced that the marketing approval of Elunate by the Pharmacy and Poisons Board of Hong Kong for the treatment of adult patients with previously treated metastatic colorectal cancer, or CRC. Elunate is a selective oral inhibitor of vascular endothelial growth factor, or VEGF, receptors -1, -2 and -3, which play a pivotal role in blocking tumor angiogenesis. This marks the first medicine to be approved under the new mechanism for registration of new drugs announced by the Government of the Hong Kong Special Administrative Region in October last year. The mechanism officially commenced on November 1, 2023. It allows drugs which are beneficial for treatment of life-threatening or severely debilitating diseases to apply for registration for use in Hong Kong, if they have supporting local clinical data and recognition from relevant experts, when they have been approved by only one reference drug regulatory authority. Hutchmed submitted the application based on the approval of Elunate from the China National Medical Products Administration, or NMPA, supported with local clinical data. Fruquintinib was also approved by the FDA in November 2023.
GGR

Hot Stocks

05:15 EST Gogoro unveils new Pulse Smartscooter - Gogoro unveiled its new flagship Smartscooter, Pulse. The company said, "The Pulse is a testament to Gogoro's ongoing commitment to performance, innovation and design and sets a new standard for what customers should expect from an advanced high-performance Smartscooter.
KNDGF

Hot Stocks

05:12 EST Kindred Sportsbook Platform signs pact with Stats Perform to utilize RunningBall - Kindred Group continues the development of its proprietary sportsbook platform, Kindred Sportsbook Platform, by signing a wide-ranging agreement with Stats Perform to utilize RunningBall official in-play sports data feed, Opta player statistics, and a range of content to entertain and inform customers. The content delivered via Stats Perform's new Content Player Pro include contextual insights, preview videos, live expected goals and in-game momentum.
CSCO...

Hot Stocks

05:09 EST Cisco, Microsoft and Samsung team on meeting room experiences - At Integrated Systems Europe, or ISE, Cisco (CSCO), Microsoft (MSFT) and Samsung (SSNLF) announced new meeting room solutions to deliver enhanced collaboration experiences for hybrid meetings. The companies unveiled integrated video collaboration solutions for Cisco Room Series. The solutions feature Front Row - a content layout for Microsoft Teams Rooms, with either Samsung's newly unveiled 105" Smart Signage with 21:9 aspect ratio and 5K resolution, or Samsung 4K Smart Signage screens.
GIB

Hot Stocks

05:03 EST CGI Inc., Posti Group enter 10-year digital messaging partnership - CGI and Posti Group have entered a 10-year strategic partnership for the development and delivery of digital multichannel messaging services. Through the agreement, Posti will partner with CGI on production of these services, and transfer 88 professionals who are based in Finland, Poland, Latvia and Estonia. In addition, CGI will partner with Posti to modernize the digital messaging technology. The collaboration will empower Posti to respond more effectively to their customers' rapidly changing expectations, as well as future cybersecurity and operational security requirements.